Page last updated: 2024-08-24

aripiprazole and Affective Psychosis, Bipolar

aripiprazole has been researched along with Affective Psychosis, Bipolar in 288 studies

Research

Studies (288)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	102 (35.42)	29.6817
2010's	158 (54.86)	24.3611
2020's	28 (9.72)	2.80

Authors

Authors	Studies
Akunne, HC; Choi, C; Favor, DA; Fay, LK; Fitzgerald, L; Johnson, DS; Nicholls, K; Repine, JT; Serpa, KA; Snyder, BJ; Whetzel, SZ; White, AD; Zhang, L	1
Baldessarini, RJ; Gaudiot, CES; Nestsiarovich, A; Tohen, M; Vieta, E; Zhu, Y	1
Appling, D; Cassidy, KA; Fuentes-Casiano, E; Levin, JB; McNamara, N; Ramirez, LF; S, FB; Sajatovic, M; Wilson, B	1
Alda, M; Beaulieu, S; Berk, M; Bond, DJ; Calabrese, J; Chakrabarty, T; Frey, BN; Goldstein, BI; Kanba, S; Kapczinski, F; Kauer-Sant'Anna, M; Kennedy, SH; Kozicky, JM; Lam, RW; Malhi, G; McIntyre, RS; Milev, RV; O'Donovan, C; Parikh, SV; Post, R; Ravindran, AV; Rej, S; Schaffer, A; Sharma, V; Suppes, T; Tourjman, V; Vazquez, G; Vieta, E; Yatham, LN	1
Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Nomura, I; Okuya, M; Sakuma, K	1
Biederman, J; Cook, E; DiSalvo, M; Faraone, SV; Farrell, A; Joshi, G; Wozniak, J; Yule, A	1
Roosen, L; Sienaert, P	1
Jauhar, S; Kaufman, KR; Kerr-Gaffney, J; Kurana, S; Strawbridge, R; Yalin, N; Young, AH	1
Alexinschi, O; Carvalho, AF; Cavaliere, L; Correll, CU; Cortese, S; Croatto, G; Fiedorowicz, JG; Firth, J; Fusar-Poli, P; Gaina, MA; Makkai, V; Miola, A; Olivola, M; Shin, JI; Soares, FC; Solmi, M; Stubbs, B; Vancampfort, D; Vianello, G; Vieta, E	1
Carvalho, AF; Hsu, CW; Hsu, TW; Liang, CS; Thompson, T; Tsai, TC; Tseng, PT; Yu, CL	1
Harlin, M; Jan, M; Jin, N; Larsen, F; Madera-McDonough, J; Such, P; Watkin, S; Yildirim, M	1
Biswas, H; Grover, S; Sahoo, MK	1
Abe, Y; Fujita, Y; Goto, J; Nabeshima, Y; Shono, M; Ueda, K; Yoshida, B	1
Beckham, C; Citrome, L; Harlin, M; Larsen, F; Madera-McDonough, J; Such, P; Yildirim, M; Zhang, Z	1
Ballester-Gracia, I; Galvez-Llompart, A; Hernandez-Viadel, M; Pérez-Almarcha, M	1
Azorin, JM; Simon, N	1
Caricasole, V; Cirnigliaro, G; Dell'Osso, B; Di Bernardo, I; Piccoli, E; Spagnolo, G	1
Bai, Y; Chen, G; Gao, K; Yang, H	1
Cattaneo, D; Franco, G; Mauri, MC; Minutillo, A; Pace, CD; Paletta, S; Reggiori, A	1
Goldberg, JF; Hassoun, Y; Sureddi, S; Tohen, M	1
Escudero, MAG; Gutiérrez-Rojas, L; Lahera, G	1
Abdullayeva, N; Coffey, BJ; Poulsen, R	1
Kesavan, M; Moazen-Zadeh, E; Pinto, JV; Saraf, G; Torres, IJ; Yatham, LN; Ziafat, K	1
Cohen, D; Coustals, N; Ménard, ML	1
Fernández Leonor, S; Pérez de Mendiola Etxezarraga, X	1
Esumi, S; Hashimoto, Y; Hatano, M; Iwata, N; Kishi, T; Matsuda, Y; Mishima, K; Miura, I; Miyake, N; Okuya, M; Sakuma, K	1
El-Mallakh, RS; Sleem, A	1
Barkhatova, AN	1
Chakrabarty, T; Keramatian, K; Saraf, G; Yatham, LN	1
Arıkan, MK; Günver, G; İlhan, R; Metin, B; Öksüz, Ö	1
Blanchard, J; Fletke, K; Kuo, S	1
Andersen, M; Bodén, R; Brandt, L; Kieler, H; Reutfors, J; Tanskanen, A; Tiihonen, J; Wingård, L	1
Estrada, G; Oudovenko, N; San, L; Vieta, E	1
Ghossoub, E; Habli, M; Maalouf, FT; Uthman, I	1
Carvalho, AF; Chang, HY; Chen, TY; Chen, YW; Chow, PC; Chu, CS; Fornaro, M; Li, DJ; Lin, PY; Solmi, M; Stubbs, B; Tseng, PT; Veronese, N; Vieta, E	1
Amerio, A; Ghaemi, SN; Odone, A; Tonna, M	1
Calabrese, JR; Deyling, E; Findling, RL; Lingler, J; Lytle, S; McNamara, NK; McVoy, M; Rowles, BM; Stansbrey, RJ; Youngstrom, EA	1
Amatniek, J; Calabrese, JR; Carson, WH; Cox, K; Hertel, P; Jin, N; Johnson, B; McQuade, RD; Nyilas, M; Perry, P; Sanchez, R; Such, P	1
Akça, ÖF; Çelikkol, Ç	1
Cuomo, A; Fagiolini, A; Goracci, A	1
Arunagiri, P; Balamurugan, E; Irene, M; Saravanakumar, M	1
Aggarwal, A; Lauriello, J; Schrimpf, L	1
Jung, M; Romanos, M	1
Ehsaei, Z; Mowla, A; Sahraian, A	1
Hibino, H; Inoue, Y; Mikami, K; Suzuki, H	1
Bastos, JR; de Miranda, AS; Machado, FS; Marciano Vieira, ÉL; Moreira, FA; Perico, KM; Teixeira, AL	1
Al-Dakkak, I; Coppin-Renz, A; Geis, U; Landsberg, W; Peters-Strickland, T; Rahman, M; van Heumen, E	1
Augusto, M; Greene, M; Sweeney, SM; Touya, M; Waters, H	2
Bukhanovskaya, O; Dobrovolskaya, N; Estrada, G; Montañés, F; Oudovenko, N; Popov, M; San, L; Vieta, E	1
Carvalho, AF; Hidalgo-Mazzei, D; Murru, A; Pacchiarotti, I; Samalin, L; Verdolini, N; Vieta, E; Young, AH	1
Frayne, J; Galbally, M; Snellen, M; Watson, SJ	1
Hebbrecht, K; Morrens, M; Neels, H; Roosens, L; Sabbe, BGC	1
Amatniek, J; Calabrese, JR; Carson, WH; Cox, K; Hertel, P; Jin, N; Johnson, B; McQuade, RD; Nyilas, M; Perry, PP; Sanchez, R; Such, P	1
Shafti, SS	1
Broder, MS; Chang, E; Greene, M; Hartry, A; Touya, M; Yan, T	1
Dias Alves, M; Micoulaud-Franchi, JA; Simon, N; Vion-Dury, J	1
Chhatlani, A; Farheen, SA; Setty, MJ; Tampi, RR	1
Belic, A; Bitter, I; Csukly, G; Déri, M; Gabri, E; Kiss, Á; Menus, Á; Monostory, K; Sirok, D; Tóth, K	1
Amerio, A; Ghaemi, SN; Odone, A	1
Andreescu, N; Grădinaru, R; Nussbaum, L; Puiu, M; Suciu, L	1
Giri, YR; Peteru, SR	1
Chakrabarty, T; Keramatian, K; Yatham, LN	1
Beccarini Crescenzi, B; Bolognesi, S; Cuomo, A; Facchi, E; Fagiolini, A; Giordano, N; Goracci, A; Neal, SM; Rossi, R	1
Angeletti, G; Brugnoli, R; Cuomo, I; De Filippis, S; Del Casale, A; Ferracuti, S; Giordano, G; Girardi, P; Kotzalidis, GD; Mazzarini, L; Rapinesi, C; Sani, G	1
Amerio, A; Ghaemi, SN; Maina, G	1
Hashimoto, T; Kurata, T; Suzuki, H	1
Chen, MH; Liou, YJ	1
Carlson, GA; Carson, WH; Correll, CU; Findling, RL; Forbes, RA; Ivanova, S; Jin, N; Mankoski, R; McQuade, RD; Nyilas, M	1
DelBello, MP; Welge, JA	1
Emslie, GJ	1
Carson, W; Findling, RL; Forbes, RA; Mankoski, R; Marcus, RM; McQuade, R; Youngstrom, E; Zhao, J	1
Dell'Osso, L; Marazziti, D; Moroni, I; Piccinni, A; Veltri, A	1
Caccia, F; Caloro, M; Cuomo, I; De Filippis, S; De Persis, S; Gentile, G; Girardi, P; Janiri, D; Kotzalidis, GD; Lionetto, L; Piazzi, G; Sciarretta, A; Simmaco, M; Simonetti, A; Telesforo, CL	1
De Berardis, D; Di Giannantonio, M; Martinotti, G; Moschetta, FS; Serroni, N	1
Bio, DS; Costa, LF; David, DP; Demétrio, FN; Fernandes, F; Missio, G; Moreno, DH; Moreno, RA; Rodrigues dos Santos, D; Soeiro-de-Souza, MG	1
Coley, KC; Fabian, TJ; Haskett, R; Kreys, TJ; Saul, MI	1
Altamura, AC; Buoli, M; Serati, M	1
Kearns, B; Ren, S; Stevenson, M; Uttley, L	1
Dore, J; Hill, SJ; Hooshmand, F; Ketter, TA; Miller, S; Portillo, N; Wang, PW	1
Allain-Veyrac, G; Gaboriau, L; Gérardin, M; Grall-Bronnec, M; Jolliet-Evin, P; Victorri-Vigneau, C	1
Brown, R; Geddes, J; Taylor, MJ	1
McKeage, K	1
Belletti, A; Cilia, R; Marotta, G; Pezzoli, G; Siri, C	1
Chennoufi, L; Cheour, M; Ouanes, S	1
Eryilmaz, G; Gül, IG; Hizli Sayar, G; Karamustafalioğlu, O; Özten, E; Yorbik, Ö	1
Arunagiri, P; Balamurugan, E; Rajeshwaran, K; Shanthakumar, J; Tamilselvan, T	1
Lu, CL; Shen, YC	1
Chan, HY; Tan, HK; Wu, WY	1
Cornelius, V; Smith, L; Taylor, DM; Young, AH	1
Carta, MG; Moro, MF	1
Malempati, RN	1
Abrial, E; Bétourné, A; Etiévant, A; Haddjeri, N; Lambás-Señas, L; Lucas, G; Scarna, H	1
Cortese, S	1
Brugnoli, R; De Filippis, S; Di Sciascio, G; Fagiolini, A; Maina, G	1
Arao, T; Kuno, F; Kurozumi, A; Okada, Y; Tanaka, Y	1
Knights, J; Rohatagi, S	1
Bilgiç, A; Yılmaz, E; Yılmaz, S	1
Citrome, L	1
Ahn, J; Joe, S; Lim, J; Park, C; Park, J	1
Baglivo, V; Balestrieri, M; Brambilla, P; Gregoraci, G; Isola, M; Meduri, M	1
Calenda, BS; Goldberg, JF; Karz, AJ; Kellner, CH; McGonigle, DP	1
Aitchison, KJ; Heald, AH; Lodhi, RJ; Malik, A; Masand, S; McAllister, VD; O'Keane, V; Sherwood, RA; Shivakumar, K; Young, LC	1
Badran, IA; Correll, CU; Curran, RL; DelBello, MP; Pedapati, EV; Peppers, V	1
Patra, S	1
Bahk, WM; Chung, S; Jeong, JH; Kim, MD; Kim, W; Lee, HB; Lee, JG; Lee, K; Park, YM; Won, S; Woo, YS; Yoon, BH	1
Das, A; Jha, S; Kumar, P; Kumar, R	1
Chang, C; Chang, HA; Kao, YC; Lin, MW; Tai, YM; Tzeng, NS; Yeh, CB	1
Naja, WJ; Tarraf, C	1
Balhara, YP; Gupta, P; Gupta, R	1
Mahapatra, A; Sagar, R; Sharma, P	1
Kelly, T; Lieberman, DZ	1
Bauer, MS; Burgess, JF; Kazis, LE; Lee, AF; Li, M; Miller, CJ; Mohr, DC; Nealon Seibert, M; Penfold, RB; Semla, TP	1
Bulbena, A; Bulbena-Cabré, A	1
Tashiro, T	1
Caballero, AR; Martínez, JS	1
Amatniek, J; Calabrese, JR; Carson, WH; Cox, K; Hertel, P; Jin, N; Johnson, B; McQuade, RD; Nyilas, M; Perry, P; Salzman, PM; Sanchez, R; Such, P	1
Boutet, C; Cancel, A; Cervello, S; Fakra, E; Giraux, P; Laurent, B; Schneider, F	1
Chang, KD	1
Nelson, R; Pumariega, AJ; Rotenberg, L	1
Croarkin, PE; Emslie, GJ; Mayes, TL	1
Boulton, DW; Carson, WH; Findling, RL; Forbes, RA; Kauffman, RE; Mallikaarjun, S; Nyilas, M; Pikalov, A; Sallee, FR; Shoaf, SE	1
Carlson, BX; Eudicone, J; Marcus, RN; Masand, PS; McQuade, RD; Pikalov, A; Vester-Blokland, E	1
Rybakowski, JK	1
Fagiolini, A	1
Arsura, E; Sethi, NK; Torgovnick, J	1
Calabrese, JR; Kemp, DE	1
Carson, WH; Cutler, AJ; Keck, PE; Marcus, RN; McQuade, RD; Orsulak, PJ; Sanchez, R; Torbeyns, A	1
Bria, P; Janiri, L; Mazza, M; Pecora, RD; Squillacioti, MR	2
Aitchison, KJ; Bienroth, M; Cookson, J; Goodwin, GM; Gray, R; Haddad, PM; Moore, B; Ratna, L; Sullivan, G; Taylor, D; Taylor, M	1
Ammerman, DK; Coley, KC; Fabian, TJ; Ganguli, R; Kim, E; Kim, MS; Saul, MI; Scipio, TM; Whitehead, R	1
Carson, WH; Lowy, A; Marcus, RN; McQuade, RD; Oren, DA; Sanchez, R; Spiller, NH; Torbeyns, AF; Young, AH	1
Balch, AH; Benson, J; Boulton, DW; Carlson, BX; Croop, R; Mallikaarjun, S; Schieber, FC	1
Jana, AK; Praharaj, SK; Sinha, VK	1
Khalid, I; Khalid, TJ; Rana, L; Roehrs, T	1
Coley, KC; Fabian, TJ; Lenze, EJ; Ruby, C; Scipio, TM	1
Smith, EJ	1
Ketzer, CR; Narvaez, J; Pheula, GF; Rohde, LA; Tramontina, S; Zeni, CP	1
Arvilommi, P; Isometsä, E; Leppämäki, S; Mantere, O; Suominen, K; Valtonen, HM	1
Jing, Y; Kim, E; Pikalov, A; Tran, QV; You, M	1
Cruz, N; Goikolea, JM; Sanchez-Moreno, J; Torres, F; Valentí, M; Vieta, E	1
De León, OA; Garza, VM; Shepherd, J	1
Ketzer, CR; Pheula, GF; Rohde, LA; Tramontina, S; Zeni, CP	1
Wagner, KD	1
Carson, WH; Chang, K; Findling, RL; Forbes, RA; Ivanova, S; Iwamoto, T; Jin, N; McQuade, RD; Nyilas, M	1
Leckband, SG; Meyer, JM; Strack, DK	1
Carbray, MJ; McGuinness, T	1
Assunção-Talbott, S; Barnes, TR; Buckley, P; Correll, CU; Eudicone, J; Kane, JM; McQuade, R; Pikalov, A; Sachs, G; Tran, QV	1
Mavrikaki, M; Nomikos, GG; Panagis, G	1
Barnett, RJ; Cauble, S; McLaren, JL	1
Chen, ST; Hsiao, YL	1
McIntyre, RS	1
Chou, JC	1
Anghelescu, I; Born, C; Langosch, J; Luborzewski, A; Quante, A; Schommer, N; Wolf, J; Zeugmann, S	1
Barth, KS; Garner, A; Phan, SV; Snarr, BS; VandenBerg, AM	1
Deng, C; Huang, XF; Lian, J; Pai, N	1
Baudelet, C; Marcus, RN; McQuade, RD; Owen, R; Sanchez, R; Vieta, E	1
Baker, RA; Calabrese, JR; Eudicone, JM; Kemp, DE; Pikalov, A; Tran, QV	1
Kovács, G	1
Lazarus, A; Quon, P; Tafesse, E; Woodward, TC	1
Carson, WH; El Mallakh, RS; Marcus, R; McQuade, R; Rollin, L; Vieta, E	1
Baker, RA; Chambers, JS; Eudicone, JM; Kemp, DE; McQuade, RD	1
De Fazio, P; Girardi, P; Maina, G; Mauri, M; Mauri, MC; Monteleone, P; Perini, GI; Perugi, G; Rossi, A	1
Carson, W; Cziraky, MJ; Delorenze, G; Niemcryk, SJ; Oliveria, SA; Phillips, S; Quesenberry, CP; Skovron, ML; Tsai, AL; Ulcickas Yood, M; Wells, K; Willey, VJ	1
Fountoulakis, KN; Schmidt, F; Vieta, E	1
Calabrese, JR; Carlson, BX; Eudicone, JM; Ganocy, S; Kemp, DE; Marcus, RN; McQuade, RD; Owen, R; Tran, QV; Vester-Blokland, E	1
Brecher, M; Calabrese, JR; Carlson, BX; Edwards, S; Eudicone, JM; Evoniuk, G; Ganocy, SJ; Jansen, W; Kemp, DE; Leon, AC; Minkwitz, M; Pikalov, A; Stassen, HH; Szegedi, A; Tohen, M; Van Willigenburg, AP	1
Leinonen, E; Valtonen, HM; Viikki, M	1
Albayrak, Y; Caykoylu, A; Ekinci, O; Ugurlu, GK	1
Katzman, MA	1
Yatham, LN	1
Casamassima, F; Fagiolini, A; Forgione, RN; Marra, FS; Nitti, M	1
Carson, W; Khan, A; Marcus, R; Morris, B; Rollin, L; Sanchez, R; Timko, K	1
Andel, R; Becker, MA; Boaz, TL; Chandler, K; Desmarais, SL; Howe, A; Van Dorn, RA	1
Bouckaert, F; De Schutter, P; Peuskens, J	1
Healy, D; Jureidini, JN; Parry, PI; Rosenlicht, NZ; Spielmans, GI; Tsai, AC	1
Eriksson, J; Kasteng, F; Lindgren, P; Sennfält, K	1
Carson, WH; Forbes, RA; Mankoski, R; Mathew, SJ; Zhao, J	1
Calabrese, JR; Demeter, CA; Findling, RL; Frazier, TW; Lingler, J; McNamara, NK; Otto, BD; Rowles, BM; Stansbrey, RJ; Youngstrom, EA	1
Bauer, LK; Januzzi, JL; Leskov, I; Mukherji, EH; Tanev, KS	1
Diaz-Atienza, F; Gurpegui, M; Gutiérrez-Rojas, L; Jurado, D; Martínez-Ortega, JM	1
Bastiampillai, T; Dhillon, R; Goh, T	1
Abbar, M; Ågren, H; Altamura, AC; Bellivier, F; Fountoulakis, KN; Goodwin, GM; Grunze, H; Holsboer-Trachsler, E; Licht, RW; Pitchot, W; Schlaepfer, TE; Vieta, E	1
Ahn, YM; Bahk, WM; Chung, MY; Chung, SK; Kim, DH; Kim, JG; Lee, JH; Lee, KH; Paik, KC; Woo, YS; Yoon, BH	1
Karadağ, F; Tan, D; Unal, F	1
Adegbite, C; Calabrese, JR; Demeter, CA; Findling, RL; Frazier, TW; McNamara, NK; Rowles, BM; Stansbrey, RJ; Wynbrandt, JL; Youngstrom, EA	1
Chen, CK; Chou, MC; Chou, WJ; Huang, YS; Tang, CS; Wang, LJ; Yeh, CB	1
Dhillon, S	1
Baudelet, C; Carson, WH; El-Mallakh, RS; Marcus, R; McQuade, R; Owen, R	1
Brotzge, K; El-Mallakh, RS; Manshadi, M	1
Bobo, WV; Chen, Y; Jayathilake, K; Meltzer, HY; Tang, T; Watts, K	1
Bowden, CL; Carlson, BX; Eudicone, JM; Marcus, R; McQuade, RD; Nashat, M; Thase, ME	1
Carlson, BX; Ketter, TA; Marcus, R; McQuade, RD; Sanchez, R; Sun, W; Timko, K; Vester-Blokland, E	1
Doey, T	1
Kirino, E	1
Cottencin, O; Geoffroy, PA; Goddefroy, G; Rolland, B	1
Ishigooka, J; Kanba, S; Kawasaki, H; Kinoshita, T; Kuroki, T; Sakamoto, K	1
Khemiri, L; Moreira, T; Runeson, L	1
Magno Zito, J; Safer, AM; Safer, DJ	1
Isogai, S; Kasai, E; Mori, N; Morimoto, S; Nakasato, K; Suzuki, K; Takagai, S	1
Bobmanuel, S; Davies, W; Dratcu, L; Farmer, A; George, M; Rana, T; Singh, M; Turner, M	1
Bradshaw, B; Henry, J; Macedo, LR; Marino, J	1
Alvir, JM; Berger, A; Edelsberg, J; Mychaskiw, MA; Oster, G; Sanders, KN	1
de Bartolomeis, A; Perugi, G	1
Bauer, MS; Kilbourne, AM; Lai, Z; Mohr, DC; Penfold, RB; Seibert, MN	1
Andersson, C; Findling, RL; Mankoski, R; Marcus, R; McQuade, R; Youngstrom, EA; Zhao, J	1
Capapey, J; Colom, F; Goikolea, JM; Grande, I; Sanchez-Moreno, J; Torres, I; Undurraga, J; Valentí, M; Vieta, E	1
Lin, CC; Lin, HY; Liu, CC	1
Aulisa, AG; Bocchino, L; Marzetti, E; Scudieri, G; Teramo, S	1
Baker, RA; Carlson, BX; De Hert, M; Eudicone, JM; Fyans, P; Kemp, DE; Marler, SV; Rahman, Z	1
Ammerman, D; Baker, RA; Carlson, BX; Fountoulakis, KN; Fyans, P; Marler, SV; Rahman, Z; Yatham, LN	1
Bienroth, M; Curtis, V; Debenham, M; George, M; Gonzalez, D; Jones, S; Pitsi, D	1
Almeida, JR; Axelson, DA; Birmaher, B; Diler, RS; Ladouceur, CD; Pan, LA; Phillips, ML; Segreti, A	1
Goodnick, PJ; Jerry, JM	1
Ali, M; Ingenito, G; Keck, PE; Liebeskind, A; Marcus, R; Saha, A; Tourkodimitris, S	1
Green, B	1
Lyseng-Williamson, KA; Perry, CM	1
Crismon, ML; DeLeon, A; Patel, NC	1
Davids, E; Fischer, B; Gastpar, M	1
Bowers, MB; Cooper, C; Lim, S; Pralea, C; Schnitt, J	1
Andrade, C	1
Jagadheesan, K; Muirhead, D	1
Durkin, JP	1
Barzman, DH; Campbell, P; DelBello, MP; Delgado, SV; Fleck, DE; Gernert, B; Kowatch, RA; Pathak, S; Rappaport, K; Strakowski, SM	1
Aleardi, M; Biederman, J; Falzone, R; McDonnell, MA; Mick, E; Spencer, T; Wozniak, J	1
Errico, JR; Yates, WR	1
Keck, PE	1
Vieta, E	1
Winter, AS; Witschy, JK	1
Kinghorn, WA; McEvoy, JP	1
Beard, L; Brown, ES; Garza, M; Jeffress, J; Liggin, JD	1
Tsai, SJ	1
Baldessarini, RJ; Centorrino, F; Cimbolli, P; Cincotta, SL; Fogarty, KV; Salvatore, P; Sani, G; Thompson, TA	1
Berk, M; Bourin, M; Dodd, S; Ivanovski, B; Lagopoulos, J; Malhi, GS; Mitchell, PB	1
Abou-Gharbia, N; Bourin, M; Carson, W; Iwamoto, T; Marcus, R; McQuade, R; Sanchez, R; Stock, E; Swanink, R; Vieta, E	1
Janvier, YM; Rugino, TA	1
Fleischhacker, WW	1
Bennett, N; Hirsch, J; Kafantaris, V; Saito, E	1
Basson, BR; Treuer, T	1
Barnas, ME; Hussain, N; Petrides, G	1
Murphy, TK; Negin, B	1
Hatchett, AD; Zacher, JL	1
Abou-Gharbia, N; Carson, W; Impellizzeri, C; Iwamoto, T; Kaplita, S; Marcus, R; McQuade, R; Rollin, L; Sachs, G; Sanchez, R; Stock, E	1
Raja, M	1
Calabrese, JR; Carlson, BX; Carson, WH; Keck, PE; Marcus, RN; McQuade, RD; Rollin, LM; Sanchez, R	1
Desarkar, P; Sinha, VK; Thakur, A	1
Lacasse, JR; Leo, J	1
Ali, S; Patel, P; Pearlman, RL; Upadhyay, A	1
Cipriani, A; Geddes, JR; Rendell, JM	1
Ehret, MJ; Levin, GM	1
Coffey, B; Jummani, R; Vito, J	1
Chou, JC; Fazzio, L	1
Correll, CU; Frederickson, AM; Kane, JM; Manu, P	1
Sokolski, KN	1
Padala, PR; Petty, F; Wengel, SP	1
Altshuler, LL; Frye, MA; Keck, PE; Leverich, GS; Martens, B; McElroy, SL; Post, RM; Stanford, K; Suppes, T	1
Dago, PL; Fleck, J; Gilmer, WS; Karaffa, M; Kemp, DE; Straus, JL	2
Adler, CM; DelBello, MP; Singh, MK	1
Modestin, J; Schneiter, R; Traber, R	1
Auby, P; Manos, G; Marcus, RN; McQuade, RD; Oren, DA; Stock, E; Zimbroff, DL	1
Baghai, TC; Born, C; Eser, D; Häfner, S; Hecht, S; Hermisson, I; Nothdurfter, C; Rupprecht, R; Schüle, C	1
Konarski, JZ; McIntyre, RS; Miranda, A; Soczynska, JK; Woldeyohannes, HO	1
Behere, RV; Gangadhar, BN; Naveen, MN; Venkatasubramanian, G	1
Citrome, LL; Crandall, DT; Currier, GW; Manos, G; McQuade, R; Oren, D; Pikalov, AA; Zimbroff, DL	1
Sahoo, S	1
Konarski, JZ; McIntyre, RS; Miranda, A; Soczynska, JK; Woldeyohannes, HO; Yasgur, BS	1
Constant, EL; Emmanuel, H; Hermans, E; Jean-Jean, A; Koener, B; Maloteaux, JM	1
Aleardi, M; Biederman, J; Doyle, R; Hammerness, P; Joshi, G; Kotarski, M; Mick, E; Spencer, T; Wozniak, J	1
Lorenz, RA; Weinstein, B	1
Carlson, B; Eudicone, J; McQuade, R; Pikalov, A; Suppes, T	1
Crandall, DT; Gaulin, BD; Gutierrez-Esteinou, R; Marcus, RN; McQuade, RD; Pikalov, A; Pultz, JA; Sachs, GS; Sanchez, R	1
de Souza, CK; Pheula, GF; Rohde, LA; Tramontina, S; Zeni, CP	1
Jain, R; Skale, TG	1
Calabrese, JR; Carlson, BX; Carson, WH; Eudicone, JM; Keck, PE; Marcus, RN; McIntyre, RS; McQuade, RD; Sanchez, R	1
Perlis, RH	1
Bowden, CL; Carson, WH; Jonas, A; Khan, A; Marcus, RN; McQuade, RD; Owen, R; Thase, ME; Wu, X	1
Calabrese, JR; Gajwani, P; Ganocy, SJ; Gao, K; Kemp, DE; Muzina, DJ	1
Chriki, LS; Dunn, RT; Filkowski, MM; Ghaemi, SN; Stan, VA	1
Blow, FC; Cassidy, KA; Coconcea, N; Hays, RW; Ignacio, RV; Meyer, WJ; Sajatovic, M	1
Sanford, M; Scott, LJ	1
Gregoriou, S; Karagiorga, T; Kontochristopoulos, G; Rigopoulos, D; Stratigos, A; Volonakis, K	1
Carlson, BX; Eudicone, J; Frye, MA; Marcus, RN; McQuade, RD; Pikalov, A	1
Lo, B; Pizon, A	1
Carlson, BX; Eudicone, JM; Marcus, RN; McQuade, RD; Momah, C; Muzina, DJ; Pikalov, A; Sanchez, R	1

Reviews

76 review(s) available for aripiprazole and Affective Psychosis, Bipolar

Article	Year
Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2022, Volume: 54 Topics: Adult; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone	2022
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations. Bipolar disorders, 2021, Volume: 23, Issue:8 Topics: Antipsychotic Agents; Anxiety; Aripiprazole; Bipolar Disorder; Canada; Humans; Olanzapine; Valproic Acid	2021
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials. Molecular psychiatry, 2022, Volume: 27, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female; Haloperidol; Humans; Lithium; Male; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Tamoxifen; Valproic Acid	2022
Evidence-based treatment strategies for rapid cycling bipolar disorder, a systematic review. Journal of affective disorders, 2022, 08-15, Volume: 311 Topics: Anticonvulsants; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Lamotrigine; Olanzapine; Quetiapine Fumarate; Valproic Acid	2022
A systematic review and meta-analysis of treatments for rapid cycling bipolar disorder. Acta psychiatrica Scandinavica, 2022, Volume: 146, Issue:4 Topics: Aripiprazole; Bipolar Disorder; Citalopram; Fluoxetine; Humans; Lamotrigine; Olanzapine; Quetiapine Fumarate; Venlafaxine Hydrochloride	2022
The impact of pharmacological and non-pharmacological interventions on physical health outcomes in people with mood disorders across the lifespan: An umbrella review of the evidence from randomised controlled trials. Molecular psychiatry, 2023, Volume: 28, Issue:1 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Fluoxetine; Glycated Hemoglobin; Humans; Longevity; Olanzapine; Outcome Assessment, Health Care; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors	2023
Comparison of antipsychotic dose equivalents for acute bipolar mania and schizophrenia. BMJ mental health, 2023, Volume: 26, Issue:1 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Haloperidol; Humans; Mania; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia	2023
Use of long acting injectable aripiprazole before and through pregnancy in bipolar disorder: a case report. BMC pharmacology & toxicology, 2019, 08-28, Volume: 20, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dosage Forms; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Time Factors	2019
Dopamine Receptor Partial Agonists for the Treatment of Bipolar Disorder. Drugs, 2019, Volume: 79, Issue:15 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dopamine Agonists; Humans; Piperazines; Receptors, Dopamine; United States; United States Food and Drug Administration	2019
Do Asian and North American patients with bipolar disorder have similar efficacy, tolerability, and safety profile during clinical trials with atypical antipsychotics? Journal of affective disorders, 2020, 01-15, Volume: 261 Topics: Adult; Antipsychotic Agents; Aripiprazole; Asian People; Bipolar Disorder; Female; Humans; North America; Olanzapine; Quetiapine Fumarate; Risperidone; United States; Weight Gain	2020
Second Generation Antipsychotics Monotherapy as Maintenance Treatment for Bipolar Disorder: a Systematic Review of Long-Term Studies. The Psychiatric quarterly, 2020, Volume: 91, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Humans; Olanzapine; Quetiapine Fumarate; Risperidone	2020
Early intervention for people at high risk of developing bipolar disorder: a systematic review of clinical trials. The lancet. Psychiatry, 2021, Volume: 8, Issue:1 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brief Psychiatric Rating Scale; Early Medical Intervention; Humans; Psychotherapy; Randomized Controlled Trials as Topic; Treatment Outcome	2021
Aripiprazole in Children and Adolescents. Journal of child and adolescent psychopharmacology, 2021, Volume: 31, Issue:1 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Off-Label Use; Schizophrenia; Tourette Syndrome; Weight Gain	2021
Effects of a conventional mood stabilizer alone or in combination with second-generation antipsychotics on recurrence rate and discontinuation rate in bipolar I disorder in the maintenance phase: A systematic review and meta-analysis of randomized, placeb Bipolar disorders, 2021, Volume: 23, Issue:8 Topics: Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Quetiapine Fumarate; Randomized Controlled Trials as Topic	2021
Advances in the psychopharmacotherapy of bipolar disorder type I. Expert opinion on pharmacotherapy, 2021, Volume: 22, Issue:10 Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans	2021
New Developments in the Use of Atypical Antipsychotics in the Treatment of Bipolar Disorder: a Systematic Review of Recent Randomized Controlled Trials. Current psychiatry reports, 2021, 05-08, Volume: 23, Issue:7 Topics: Adolescent; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Humans; Quetiapine Fumarate; Randomized Controlled Trials as Topic	2021
Efficacy, safety and tolerability of aripiprazole in bipolar disorder: An updated systematic review and meta-analysis of randomized controlled trials. Progress in neuro-psychopharmacology & biological psychiatry, 2017, 10-03, Volume: 79, Issue:Pt B Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Randomized Controlled Trials as Topic	2017
Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice. Journal of affective disorders, 2018, 03-01, Volume: 228 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Breast Feeding; Female; Humans; Infant; Lactation; Peripartum Period; Pregnancy; Pregnancy Complications; Prospective Studies; Psychotropic Drugs; Retrospective Studies; Schizophrenia	2018
Aripiprazole Long-Acting Injectable for Maintenance Treatment of Bipolar I Disorder in Adults. Clinical schizophrenia & related psychoses, 2018, Volume: 11, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Delayed-Action Preparations; Humans; Injections	2018
Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines. Acta psychiatrica Scandinavica, 2018, Volume: 138, Issue:3 Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Lithium; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Practice Guidelines as Topic; Quetiapine Fumarate; Thiazoles; Valproic Acid	2018
Pharmacokinetic evaluation of the aripiprazole (once-monthly) injection for the treatment of bipolar disorder. Expert opinion on drug metabolism & toxicology, 2018, Volume: 14, Issue:10 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Chronic Disease; Delayed-Action Preparations; Drug Administration Schedule; Humans; Injections; Treatment Outcome	2018
Use of cariprazine in psychiatric disorders: A systematic review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2018, Volume: 30, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder; Humans; Piperazines; Risperidone; Schizophrenia	2018
Aripiprazole augmentation in treating comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review. Journal of affective disorders, 2019, Apr-15, Volume: 249 Topics: Antimanic Agents; Aripiprazole; Bipolar Disorder; Comorbidity; Humans; Lithium Carbonate; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors	2019
Escalation of Gambling Associated With Aripiprazole: A Case Report and Literature Review. Journal of psychiatric practice, 2019, Volume: 25, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Gambling; Humans; Middle Aged	2019
Aripiprazole with digital ingestion tracking (Abilify MyCite). The Medical letter on drugs and therapeutics, 2019, Jan-28, Volume: 61, Issue:1564 Topics: Antipsychotic Agents; Aripiprazole; Biosensing Techniques; Bipolar Disorder; Clinical Trials as Topic; Depressive Disorder, Major; Gastrointestinal Absorption; Humans; Schizophrenia; Signal Processing, Computer-Assisted	2019
Long-Acting Injectable Second-Generation/Atypical Antipsychotics for the Management of Bipolar Disorder: A Systematic Review. CNS drugs, 2019, Volume: 33, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Delayed-Action Preparations; Humans; Medication Adherence; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome	2019
Drug safety evaluation of aripiprazole in bipolar disorder. Expert opinion on drug safety, 2019, Volume: 18, Issue:6 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Delayed-Action Preparations; Humans; Weight Gain	2019
Long-Acting Injectable (LAI) Aripiprazole Formulations in the Treatment of Schizophrenia and Bipolar Disorder: a Systematic Review. Clinical drug investigation, 2019, Volume: 39, Issue:8 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Delayed-Action Preparations; Humans; Injections, Intramuscular; Male; Recurrence; Schizophrenia	2019
Updates in treating comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review. Journal of affective disorders, 2019, 09-01, Volume: 256 Topics: Adult; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Comorbidity; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Obsessive-Compulsive Disorder; Treatment Outcome; Young Adult	2019
Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review. Journal of affective disorders, 2014, Volume: 152-154 Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Therapy, Combination; Humans; Long-Term Care; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome	2014
Aripiprazole for the treatment and prevention of acute manic and mixed episodes in bipolar I disorder in children and adolescents: a NICE single technology appraisal. PharmacoEconomics, 2013, Volume: 31, Issue:11 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Clinical Trials as Topic; Cost-Benefit Analysis; Humans; Piperazines; Precision Medicine; Quinolones	2013
Aripiprazole alone or in combination for acute mania. The Cochrane database of systematic reviews, 2013, Dec-17, Issue:12 Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haloperidol; Humans; Lithium Compounds; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Valproic Acid	2013
Aripiprazole: a review of its use in the treatment of manic episodes in adolescents with bipolar I disorder. CNS drugs, 2014, Volume: 28, Issue:2 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; European Union; Humans; Medication Adherence; Piperazines; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic	2014
An update on the treatment of mixed bipolar states: what is new in 2013? Journal of affective disorders, 2014, Volume: 158 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Calcitonin; Dibenzocycloheptenes; Heterocyclic Compounds, 4 or More Rings; Humans; Olanzapine; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Thiazoles; Treatment Outcome	2014
Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis. Acta psychiatrica Scandinavica, 2014, Volume: 130, Issue:6 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lamotrigine; Lithium Compounds; Lurasidone Hydrochloride; Monoamine Oxidase Inhibitors; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles; Treatment Outcome; Triazines; Valproic Acid	2014
Evaluating aripiprazole as a potential bipolar disorder therapy for adults. Expert opinion on investigational drugs, 2014, Volume: 23, Issue:12 Topics: Adult; Animals; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Piperazines; Quinolones; Treatment Outcome	2014
A meta-analysis of efficacy and safety of aripiprazole in adult and pediatric bipolar disorder in randomized controlled trials and observational studies. Journal of affective disorders, 2016, Volume: 191 Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Bipolar Disorder; Child; Gastrointestinal Diseases; Humans; Hyperprolactinemia; Male; Middle Aged; Observational Studies as Topic; Randomized Controlled Trials as Topic; Treatment Outcome; Weight Gain; Young Adult	2016
The use of atypical antipsychotics in pediatric bipolar disorder. The Journal of clinical psychiatry, 2008, Volume: 69 Suppl 4 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Bipolar Disorder; Child; Comorbidity; Dibenzothiazepines; Disorders of Excessive Somnolence; Humans; Obesity; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Weight Gain	2008
Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:7 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Child; Child, Preschool; Clozapine; Dibenzothiazepines; Humans; Neuroleptic Malignant Syndrome; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Thiazoles	2008
Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis. The international journal of neuropsychopharmacology, 2010, Volume: 13, Issue:1 Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Combinations; Drug Therapy, Combination; Fluoxetine; Humans; Olanzapine; Piperazines; Placebos; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome	2010
Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:7 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Haloperidol; Humans; Hypnotics and Sedatives; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2010
Aripiprazole for the maintenance treatment of bipolar I disorder: A review. Clinical therapeutics, 2010, Volume: 32 Suppl 1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Double-Blind Method; Humans; Lithium; Metabolic Diseases; Obesity; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Secondary Prevention; Treatment Outcome	2010
Mixed episodes with psychotic features. CNS spectrums, 2009, Volume: 14, Issue:11 Suppl 1 Topics: Acute Disease; Adult; Affect; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Evidence-Based Medicine; Hospitalization; Humans; Male; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Treatment Outcome; Valproic Acid	2009
Aripiprazole in acute mania and long-term treatment of bipolar disorder: a critical review by an Italian working group. Clinical drug investigation, 2010, Volume: 30, Issue:12 Topics: Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Italy; Medication Adherence; Piperazines; Quinolones; Time Factors; Treatment Outcome	2010
Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis. Journal of affective disorders, 2011, Volume: 133, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depression; Humans; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome	2011
Predictive value of early improvement in bipolar depression trials: a post-hoc pooled analysis of two 8-week aripiprazole studies. Psychopharmacology bulletin, 2010, Volume: 43, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Double-Blind Method; Drug Resistance; Female; Humans; Linear Models; Logistic Models; Male; Middle Aged; Multicenter Studies as Topic; Piperazines; Predictive Value of Tests; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Remission Induction; Sensitivity and Specificity; Time Factors; Treatment Outcome	2010
Aripiprazole: a clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness. Journal of affective disorders, 2011, Volume: 128 Suppl 1 Topics: Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Anxiety Disorders; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Mental Disorders; Piperazines; Quinolones	2011
A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder. Journal of affective disorders, 2011, Volume: 128 Suppl 1 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Therapy, Combination; Humans; Lithium Compounds; Piperazines; Quinolones; Secondary Prevention	2011
Aripiprazole for the treatment of bipolar disorder: a review of current evidence. Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:3 Topics: Administration, Oral; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Injections, Intramuscular; Piperazines; Quinolones	2011
Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature. PLoS medicine, 2011, Volume: 8, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Evidence-Based Medicine; Humans; Lithium; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Secondary Prevention; Treatment Outcome	2011
Aripiprazole in patients with bipolar mania and beyond: an update of practical guidance. Current medical research and opinion, 2011, Volume: 27, Issue:12 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Hypnotics and Sedatives; Male; Piperazines; Practice Guidelines as Topic; Quinolones	2011
Aripiprazole: a review of its use in the management of mania in adults with bipolar I disorder. Drugs, 2012, Jan-01, Volume: 72, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Piperazines; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome	2012
Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms. International journal of psychiatry in clinical practice, 2012, Volume: 16, Issue:2 Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Depression; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nausea; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult	2012
Aripiprazole in pediatric psychosis and bipolar disorder: a clinical review. Journal of affective disorders, 2012, Volume: 138 Suppl Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Humans; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia	2012
Efficacy and safety of aripiprazole in child and adolescent patients. European child & adolescent psychiatry, 2012, Volume: 21, Issue:7 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Bipolar Disorder; Child; Humans; Piperazines; Quinolones; Schizophrenia	2012
Age-grouped differences in bipolar mania. Comprehensive psychiatry, 2012, Volume: 53, Issue:8 Topics: Adolescent; Adult; Age Factors; Aggression; Anger; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Benzodiazepines; Bipolar Disorder; Child; Clinical Trials as Topic; Comorbidity; Defense Mechanisms; Female; Humans; Irritable Mood; Male; Middle Aged; Motor Activity; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychometrics; Quinolones; Sexual Behavior; Thinking; Young Adult	2012
Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance. Expert opinion on pharmacotherapy, 2012, Volume: 13, Issue:14 Topics: Affect; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Therapy, Combination; Humans; Lithium Compounds; Piperazines; Quinolones; Valproic Acid	2012
Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol. Journal of affective disorders, 2013, Jan-25, Volume: 144, Issue:3 Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Depressive Disorder; Dibenzothiazepines; Double-Blind Method; Drug Industry; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Support as Topic; Risperidone; Thiazoles	2013
Aripiprazole: profile on efficacy and safety. Expert opinion on pharmacotherapy, 2002, Volume: 3, Issue:12 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brain; Cardiovascular System; Clinical Trials as Topic; Digestive System; Dyskinesia, Drug-Induced; Humans; Mental Disorders; Piperazines; Quinolones; Schizophrenia	2002
Focus on aripiprazole. Current medical research and opinion, 2004, Volume: 20, Issue:2 Topics: Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Interactions; Humans; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia	2004
Aripiprazole: in acute mania associated with bipolar I disorder. CNS drugs, 2004, Volume: 18, Issue:6 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Evaluation; Drug Tolerance; Humans; Piperazines; Practice Guidelines as Topic; Quinolones	2004
Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability. Clinical therapeutics, 2004, Volume: 26, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia	2004
[Aripiprazole: a new atypical antipsychotic drug]. Fortschritte der Neurologie-Psychiatrie, 2004, Volume: 72, Issue:9 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Piperazines; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic	2004
The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania. The Journal of clinical psychiatry, 2005, Volume: 66 Suppl 3 Topics: Acute Disease; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Double-Blind Method; Humans; Lithium; Olanzapine; Piperazines; Placebos; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome	2005
The treatment of mixed states and the risk of switching to depression. European psychiatry : the journal of the Association of European Psychiatrists, 2005, Volume: 20, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Electroconvulsive Therapy; Haloperidol; Health Education; Humans; Lithium Carbonate; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Thiazoles	2005
Aripiprazole: pharmacology, efficacy, safety and tolerability. Expert review of neurotherapeutics, 2005, Volume: 5, Issue:3 Topics: Animals; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Piperazines; Quinolones; Schizophrenia	2005
A typical mood stabilizers: a "typical role for atypical antipsychotics. Acta psychiatrica Scandinavica. Supplementum, 2005, Issue:426 Topics: Affect; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Secondary Prevention; Sulpiride; Thiazoles	2005
Aripiprazole. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:12 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Piperazines; Quinolones; Schizophrenia; Schizophrenic Psychology	2005
Haloperidol alone or in combination for acute mania. The Cochrane database of systematic reviews, 2006, Jul-19, Issue:3 Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dibenzothiazepines; Drug Therapy, Combination; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Valproic Acid	2006
Long-term use of atypical antipsychotics in bipolar disorder. Pharmacotherapy, 2006, Volume: 26, Issue:8 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Administration Schedule; Drug Costs; Humans; Olanzapine; Piperazines; Practice Guidelines as Topic; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Thiazoles; United States	2006
Maintenance treatment of bipolar disorder: Applying research to clinical practice. Journal of psychiatric practice, 2006, Volume: 12, Issue:5 Topics: Anticonvulsants; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Evidence-Based Medicine; Humans; Lamotrigine; Lithium Carbonate; Olanzapine; Piperazines; Quinolones; Triazines; Valproic Acid	2006
Aripiprazole: pharmacology and evidence in bipolar disorder. Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:7 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clinical Trials as Topic; Humans; Piperazines; Quinolones	2007
Maintenance treatment in bipolar disorder: a focus on aripiprazole. Expert review of neurotherapeutics, 2007, Volume: 7, Issue:8 Topics: Antidepressive Agents; Aripiprazole; Bipolar Disorder; Humans; Piperazines; Quinolones; Time	2007
Treatment of bipolar disorder: the evolving role of atypical antipsychotics. The American journal of managed care, 2007, Volume: 13, Issue:7 Suppl Topics: Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Benzodiazepines; Bipolar Disorder; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Humans; Hyperprolactinemia; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome; Weight Gain	2007
A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Double-Blind Method; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Design; Risperidone; Schizophrenia; Sleep Stages; Thiazoles; Treatment Outcome	2008
Intramuscular aripiprazole : a review of its use in the management of agitation in schizophrenia and bipolar I disorder. CNS drugs, 2008, Volume: 22, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Injections, Intramuscular; Piperazines; Psychomotor Agitation; Quinolones; Schizophrenia	2008

Trials

60 trial(s) available for aripiprazole and Affective Psychosis, Bipolar

Article	Year
Long-Acting Injectable Antipsychotic Medication Plus Customized Adherence Enhancement in Poor Adherence Patients With Bipolar Disorder. The primary care companion for CNS disorders, 2021, Sep-16, Volume: 23, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Medication Adherence; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales	2021
A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder. CNS drugs, 2023, Volume: 37, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Delayed-Action Preparations; Female; Humans; Injections; Male; Middle Aged; Schizophrenia	2023
Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 mg: Secondary Analysis of Outcomes in Adult Patients With Schizophrenia in a Randomized, Open-label, Parallel-Arm, Pivotal Study. The Journal of clinical psychiatry, 2023, 09-04, Volume: 84, Issue:5 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Humans; Schizophrenia	2023
Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder. BMC psychiatry, 2017, 04-04, Volume: 17, Issue:1 Topics: Administration, Inhalation; Adolescent; Adult; Aged; Aggression; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clinical Protocols; Humans; Injections, Intramuscular; Loxapine; Male; Middle Aged; Psychomotor Agitation; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Young Adult	2017
A Double-Blind and Placebo-Controlled Trial of Aripiprazole in Symptomatic Youths at Genetic High Risk for Bipolar Disorder. Journal of child and adolescent psychopharmacology, 2017, Volume: 27, Issue:10 Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Child of Impaired Parents; Child, Preschool; Double-Blind Method; Female; Genetic Predisposition to Disease; Humans; Male; Risk Factors	2017
Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder. Journal of affective disorders, 2018, Volume: 227 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections; Male; Middle Aged; Quality of Life; Surveys and Questionnaires	2018
Aripiprazole as an adjuvant treatment for obsessive and compulsive symptoms in manic phase of bipolar disorder: A randomized, double-blind, placebo-controlled clinical trial. Progress in neuro-psychopharmacology & biological psychiatry, 2018, 06-08, Volume: 84, Issue:Pt A Topics: Adult; Aripiprazole; Bipolar Disorder; Chemotherapy, Adjuvant; Clonazepam; Compulsive Behavior; Double-Blind Method; Female; Humans; Lithium Compounds; Male; Obsessive Behavior; Psychiatric Status Rating Scales; Psychotropic Drugs; Treatment Outcome	2018
Cost-effectiveness of long-acting injectable aripiprazole once-monthly 400 mg in bipolar I disorder in the USA. Journal of comparative effectiveness research, 2018, Volume: 7, Issue:7 Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Administration Schedule; Drug Costs; Female; Humans; Injections, Intramuscular; Male; Markov Chains; Middle Aged; Paliperidone Palmitate; Piperazines; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Young Adult	2018
PLACID study: A randomized trial comparing the efficacy and safety of inhaled loxapine versus intramuscular aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2018, Volume: 28, Issue:6 Topics: Administration, Inhalation; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Injections, Intramuscular; Loxapine; Male; Middle Aged; Psychiatric Status Rating Scales; Psychomotor Agitation; Schizophrenia; Single-Blind Method; Treatment Outcome; Young Adult	2018
The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal study. Journal of affective disorders, 2018, 12-01, Volume: 241 Topics: Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Conduct Disorder; Double-Blind Method; Female; Humans; Maintenance Chemotherapy; Male; Middle Aged; Psychomotor Agitation; Substance Withdrawal Syndrome; Weight Gain; Young Adult	2018
Aripiprazole Versus Lithium in Management of Acute Mania: a Randomized Clinical Trial. East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan, 2018, Volume: 28, Issue:3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Double-Blind Method; Humans; Lithium Carbonate; Male; Treatment Outcome; Young Adult	2018
Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study. Bipolar disorders, 2013, Volume: 15, Issue:2 Topics: Adolescent; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome; United States	2013
Clinical significance of treatment effects with aripiprazole versus placebo in a study of manic or mixed episodes associated with pediatric bipolar I disorder. Journal of child and adolescent psychopharmacology, 2013, Volume: 23, Issue:2 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Female; Humans; Male; Parents; Piperazines; Psychiatric Status Rating Scales; Quinolones; Reproducibility of Results; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome	2013
Intramuscular aripiprazole in the acute management of psychomotor agitation. Pharmacotherapy, 2013, Volume: 33, Issue:6 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Hospitals, University; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Schizophrenia; Time Factors; Treatment Outcome; Young Adult	2013
The ARIQUELI study: potentiation of quetiapine in bipolar I nonresponders with lithium versus aripiprazole. Trials, 2013, Jun-27, Volume: 14 Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brazil; Clinical Protocols; Dibenzothiazepines; Drug Synergism; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Male; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Quinolones; Research Design; Time Factors; Treatment Outcome; Young Adult	2013
Development and application of an aggregate adherence metric derived from population pharmacokinetics to inform clinical trial enrichment. Journal of pharmacokinetics and pharmacodynamics, 2015, Volume: 42, Issue:3 Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Male; Medication Adherence; Middle Aged; Models, Biological; Schizophrenia; Young Adult	2015
Effects of switching to aripiprazole from current atypical antipsychotics on subsyndromal symptoms and tolerability in patients with bipolar disorder. International clinical psychopharmacology, 2016, Volume: 31, Issue:5 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Drug Substitution; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Treatment Outcome	2016
Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal Study. The Journal of clinical psychiatry, 2017, Volume: 78, Issue:3 Topics: Administration, Oral; Adult; Affect; Aripiprazole; Bipolar Disorder; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Drug Substitution; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Male; Middle Aged; Recurrence; Substance Withdrawal Syndrome; Treatment Outcome	2017
Criteria for defining symptomatic and sustained remission in bipolar I disorder: a post-hoc analysis of a 26-week aripiprazole study (study CN138-010). Psychopharmacology bulletin, 2008, Volume: 41, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Double-Blind Method; Female; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Recurrence	2008
Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study. Journal of affective disorders, 2009, Volume: 112, Issue:1-3 Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Follow-Up Studies; Headache; Humans; Lithium Compounds; Male; Middle Aged; Nausea; Piperazines; Placebos; Psychiatric Status Rating Scales; Quinolones; Severity of Illness Index; Treatment Outcome; Weight Gain	2009
Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients. Psychiatry research, 2009, Jan-30, Volume: 165, Issue:1-2 Topics: Adult; Affect; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Psychometrics; Quinolones	2009
Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:18 Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Depression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Headache; Humans; Lorazepam; Male; Middle Aged; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Young Adult	2008
Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study. The British journal of psychiatry : the journal of mental science, 2009, Volume: 194, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Double-Blind Method; Endpoint Determination; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Quinolones; Treatment Outcome; Young Adult	2009
A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder. Human psychopharmacology, 2009, Volume: 24, Issue:2 Topics: Adult; Anticonvulsants; Antipsychotic Agents; Area Under Curve; Aripiprazole; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Lamotrigine; Male; Middle Aged; Piperazines; Quinolones; Sleep Initiation and Maintenance Disorders; Triazines	2009
Aripiprazole prescribing patterns and side effects in elderly psychiatric inpatients. Journal of psychiatric practice, 2009, Volume: 15, Issue:2 Topics: Aged; Aged, 80 and over; Aging; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Inpatients; Male; Mental Disorders; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Quinolones; Retrospective Studies; Schizophrenia; Treatment Outcome	2009
Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial. The Journal of clinical psychiatry, 2009, Apr-21, Volume: 70, Issue:5 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Humans; Pilot Projects; Piperazines; Quinolones; Surveys and Questionnaires	2009
Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial. Journal of child and adolescent psychopharmacology, 2009, Volume: 19, Issue:5 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Piperazines; Psychiatric Status Rating Scales; Quinolones; Severity of Illness Index	2009
Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:10 Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Child, Preschool; Comorbidity; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome	2009
Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study. Human psychopharmacology, 2010, Volume: 25, Issue:2 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antimanic Agents; Aripiprazole; Bipolar Disorder; Citalopram; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Piperazines; Quality of Life; Quinolones; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires	2010
Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study. Current medical research and opinion, 2010, Volume: 26, Issue:6 Topics: Adult; Antimanic Agents; Aripiprazole; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Male; Middle Aged; Piperazines; Quinolones; Treatment Outcome; Valproic Acid	2010
Metabolic syndrome in patients enrolled in a clinical trial of aripiprazole in the maintenance treatment of bipolar I disorder: a post hoc analysis of a randomized, double-blind, placebo-controlled trial. The Journal of clinical psychiatry, 2010, Volume: 71, Issue:9 Topics: Adult; Antipsychotic Agents; Argentina; Aripiprazole; Bipolar Disorder; Comorbidity; Cross-Sectional Studies; Double-Blind Method; Female; Humans; Incidence; Long-Term Care; Male; Metabolic Syndrome; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones	2010
A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007). European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2010, Volume: 20, Issue:11 Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Piperazines; Quinolones; Secondary Prevention; Treatment Outcome	2010
Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression. Journal of affective disorders, 2011, Volume: 130, Issue:1-2 Topics: Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Lamotrigine; Olanzapine; Piperazines; Predictive Value of Tests; Psychiatric Status Rating Scales; Quetiapine Fumarate; Quinolones; Remission Induction; Sensitivity and Specificity; Time Factors; Treatment Outcome; Triazines	2011
Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study. Bipolar disorders, 2011, Volume: 13, Issue:2 Topics: Adult; Antimanic Agents; Aripiprazole; Bipolar Disorder; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium; Longitudinal Studies; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Time Factors; Treatment Outcome; Valproic Acid	2011
Young mania rating scale line item analysis in pediatric subjects with bipolar I disorder treated with aripiprazole in a short-term, double-blind, randomized study. Journal of child and adolescent psychopharmacology, 2011, Volume: 21, Issue:4 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Comorbidity; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Inpatients; Male; Outpatients; Piperazines; Placebos; Psychiatric Status Rating Scales; Quinolones; Time Factors; Treatment Outcome	2011
An open-label study of aripiprazole in children with a bipolar disorder. Journal of child and adolescent psychopharmacology, 2011, Volume: 21, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Child, Preschool; Comorbidity; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Outpatients; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome; Weight Gain	2011
Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial. Human psychopharmacology, 2011, Volume: 26, Issue:8 Topics: Adult; Aripiprazole; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Time Factors; Treatment Outcome; Valproic Acid	2011
Double-blind, randomized, placebo-controlled long-term maintenance study of aripiprazole in children with bipolar disorder. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:1 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Child, Preschool; Double-Blind Method; Female; Humans; Male; Piperazines; Quinolones	2012
A 40-week double-blind aripiprazole versus lithium follow-up of a 12-week acute phase study (total 52 weeks) in bipolar I disorder. Journal of affective disorders, 2012, Volume: 136, Issue:3 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Double-Blind Method; Female; Follow-Up Studies; Humans; Lithium Compounds; Male; Middle Aged; Piperazines; Quinolones; Young Adult	2012
Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study. Journal of psychopharmacology (Oxford, England), 2012, Volume: 26, Issue:9 Topics: Adult; Antipsychotic Agents; Aripiprazole; Atherosclerosis; Bipolar Disorder; Cohort Studies; Diagnostic and Statistical Manual of Mental Disorders; Drug Monitoring; Dyslipidemias; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; North America; Patient Dropouts; Piperazines; Psychotic Disorders; Quinolones; Risk Factors; Schizophrenia; Severity of Illness Index; Thiazoles; Weight Loss	2012
Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392). Bipolar disorders, 2012, Volume: 14, Issue:1 Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lamotrigine; Male; Middle Aged; Piperazines; Quinolones; Secondary Prevention; Treatment Outcome; Triazines	2012
A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole for the treatment of acute manic or mixed episodes in Asian patients with bipolar I disorder (the AMAZE study). The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2014, Volume: 15, Issue:2 Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Asia; Asian People; Bipolar Disorder; Double-Blind Method; Humans; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome	2014
Respondent and item level patterns of response of aripiprazole in the acute treatment of pediatric bipolar I disorder. Journal of affective disorders, 2012, Dec-20, Volume: 143, Issue:1-3 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Depression; Double-Blind Method; Female; Humans; Male; Parents; Piperazines; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome	2012
Investigation into the long-term metabolic effects of aripiprazole adjunctive to lithium, valproate, or lamotrigine. Journal of affective disorders, 2013, May-15, Volume: 148, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lamotrigine; Lithium; Male; Metabolic Syndrome; Middle Aged; Obesity; Overweight; Piperazines; Quinolones; Time Factors; Treatment Outcome; Triazines; Valproic Acid	2013
Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar I patients stratified by index manic or mixed episode. Journal of affective disorders, 2013, Volume: 147, Issue:1-3 Topics: Adult; Aripiprazole; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Longitudinal Studies; Male; Middle Aged; Piperazines; Quinolones; Secondary Prevention; Single-Blind Method; Tranquilizing Agents; Valproic Acid	2013
A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. The American journal of psychiatry, 2003, Volume: 160, Issue:9 Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Bipolar Disorder; Double-Blind Method; Female; Humans; Male; Piperazines; Placebos; Quinolones; Treatment Outcome	2003
Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:6 Topics: Adult; Ambulatory Care; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Comorbidity; Diagnosis, Dual (Psychiatry); Dopamine Agonists; Female; Humans; Male; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Receptors, Dopamine D2; Substance-Related Disorders; Treatment Outcome	2005
Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial. The British journal of psychiatry : the journal of mental science, 2005, Volume: 187 Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Double-Blind Method; Electrocardiography; Female; Haloperidol; Humans; Male; Middle Aged; Patient Dropouts; Piperazines; Prolactin; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome	2005
Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study. Journal of psychopharmacology (Oxford, England), 2006, Volume: 20, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Prolactin; Quinolones	2006
A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. The Journal of clinical psychiatry, 2006, Volume: 67, Issue:4 Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cross-Cultural Comparison; Double-Blind Method; Female; Humans; International Cooperation; Male; Pain; Piperazines; Placebos; Psychiatric Status Rating Scales; Quinolones; Secondary Prevention; Time Factors; Treatment Outcome	2006
Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2 Topics: Acute Disease; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Injections, Intramuscular; Lorazepam; Male; Nausea; Patient Dropouts; Piperazines; Psychomotor Agitation; Quinolones; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Vomiting	2007
Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2007, Volume: 8, Issue:2 Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Neurologic Examination; Personality Inventory; Piperazines; Quinolones	2007
An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder. CNS spectrums, 2007, Volume: 12, Issue:9 Topics: Adolescent; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Brief Psychiatric Rating Scale; Child; Drug Tolerance; Female; Humans; Male; Piperazines; Quinolones; Surveys and Questionnaires	2007
Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder. Journal of affective disorders, 2008, Volume: 107, Issue:1-3 Topics: Acute Disease; Adolescent; Adult; Age Distribution; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Quinolones; Sleep Initiation and Maintenance Disorders; Treatment Outcome	2008
Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial. CNS spectrums, 2007, Volume: 12, Issue:10 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Double-Blind Method; Female; Humans; Male; Piperazines; Quinolones	2007
Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:10 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depression; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; GABA Modulators; Humans; Lorazepam; Male; Piperazines; Prevalence; Prospective Studies; Quinolones; Remission Induction; Secondary Prevention; Severity of Illness Index; Surveys and Questionnaires	2007
Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:1 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Endpoint Determination; Female; Humans; Male; Middle Aged; Piperazines; Quinolones	2008
A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression. Journal of affective disorders, 2008, Volume: 110, Issue:1-2 Topics: Acute Disease; Adolescent; Adult; Akathisia, Drug-Induced; Ambulatory Care; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Drug Therapy, Combination; Endpoint Determination; Female; Humans; Lorazepam; Male; Middle Aged; Nausea; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome	2008
Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:1 Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Bipolar Disorder; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Electrocardiography; Female; Humans; Interview, Psychological; Lamotrigine; Lithium Carbonate; Male; Middle Aged; Pilot Projects; Piperazines; Prospective Studies; Quinolones; Triazines; Valproic Acid	2008
Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study. International journal of clinical practice, 2008, Volume: 62, Issue:5 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Prospective Studies; Quinolones; Treatment Outcome	2008

Other Studies

152 other study(ies) available for aripiprazole and Affective Psychosis, Bipolar

Article	Year
Discovery of PF-00217830: aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder. Bioorganic & medicinal chemistry letters, 2011, May-01, Volume: 21, Issue:9 Topics: Animals; Antipsychotic Agents; Bipolar Disorder; Drug Discovery; Haplorhini; Male; Molecular Structure; Naphthyridines; Piperazine; Piperazines; Rats; Receptors, Dopamine D2; Schizophrenia; Structure-Activity Relationship	2011
Can pediatric bipolar disorder be successfully treated when comorbid with conduct disorder? A secondary analysis of clinical trials of risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole. Journal of psychopharmacology (Oxford, England), 2022, Volume: 36, Issue:5 Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Child; Clinical Trials as Topic; Conduct Disorder; Humans; Mania; Olanzapine; Piperazines; Prospective Studies; Quetiapine Fumarate; Risperidone; Thiazoles	2022
Safety Profile of Aripiprazole During Pregnancy and Lactation: Report of 2 Cases. Turk psikiyatri dergisi = Turkish journal of psychiatry, 2023,Summer, Volume: 34, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Lactation; Pregnancy; Schizophrenia	2023
Preventive effect of aripiprazole once monthly on rehospitalization for bipolar disorder: A multicenter 1-year retrospective mirror image study. Neuropsychopharmacology reports, 2023, Volume: 43, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Patient Readmission; Retrospective Studies	2023
Aripiprazole causing false positive urine amphetamine drug screen in an adult patient with bipolar disorder. Comprehensive psychiatry, 2019, Volume: 94 Topics: Adult; Amphetamines; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; False Positive Reactions; Female; Humans; Substance Abuse Detection	2019
Paliperidone LAI and Aripiprazole LAI Plasma Level Monitoring in the Prophylaxis of Bipolar Disorder Type I with Manic Predominance. Pharmacopsychiatry, 2020, Volume: 53, Issue:5 Topics: Adolescent; Adult; Aged; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Delayed-Action Preparations; Depression; Female; Humans; Injections; Male; Mania; Middle Aged; Paliperidone Palmitate; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome; Young Adult	2020
Identifying Profiles of Patients With Bipolar I Disorder Who Would Benefit From Maintenance Therapy With a Long-Acting Injectable Antipsychotic. The Journal of clinical psychiatry, 2020, 06-16, Volume: 81, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cost-Benefit Analysis; Delayed-Action Preparations; Humans; Injections; Injections, Intramuscular; Medication Adherence; Patient Selection; Practice Guidelines as Topic; Risperidone	2020
Acute Dystonic Reaction to Aripiprazole in an Adolescent Boy. Journal of child and adolescent psychopharmacology, 2020, Volume: 30, Issue:7 Topics: Adolescent; Antiparkinson Agents; Antipsychotic Agents; Aripiprazole; Benztropine; Bipolar Disorder; Dystonia; Humans; Lithium; Male; Marijuana Abuse; Quetiapine Fumarate; Risk-Taking	2020
Aripiprazole in the treatment of bipolar disorder due to traumatic brain injury: A case description. Bipolar disorders, 2021, Volume: 23, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brain Injuries, Traumatic; Humans; Piperazines	2021
[About diagnosis and therapy of bipolar disorder]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2021, Volume: 121, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans	2021
Gamma oscillations predict treatment response to aripiprazole in bipolar disorder. Journal of affective disorders, 2021, 11-01, Volume: 294 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Piperazines; Quinolones; Retrospective Studies; Treatment Outcome	2021
23-year-old woman • syncopal episode • sinus bradycardia • history of bipolar disorder • Dx? The Journal of family practice, 2021, Volume: 70, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Bradycardia; Electrocardiography; Female; Humans; Syncope; Young Adult	2021
Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations. Journal of affective disorders, 2017, 08-01, Volume: 217 Topics: Adolescent; Adult; Aged; Antimanic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Cohort Studies; Drug Therapy, Combination; Female; Hospitalization; Humans; Lithium Compounds; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Registries; Secondary Prevention; Valproic Acid; Young Adult	2017
Mania induced by adalimumab in a patient with ankylosing spondylitis. International journal of psychiatry in medicine, 2016, Volume: 51, Issue:6 Topics: Adalimumab; Adult; Antimanic Agents; Antirheumatic Agents; Aripiprazole; Bipolar Disorder; Humans; Male; Spondylitis, Ankylosing; Treatment Outcome; Valproic Acid	2016
The Osler's view: Treating comorbid bipolar disorder and obsessive-compulsive disorder. The Australian and New Zealand journal of psychiatry, 2017, Volume: 51, Issue:9 Topics: Adult; Affect; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clomipramine; Depression, Postpartum; Diagnosis, Differential; Female; Fluvoxamine; Humans; Lithium Compounds; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales	2017
Aripiprazole Treatment in a 9-Year-Old Child With OCD and Hypomania Symptoms Possibly Related to Herbal Medicines: A Case Report. Journal of clinical psychopharmacology, 2018, Volume: 38, Issue:1 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Female; Humans; Obsessive-Compulsive Disorder; Plant Preparations; Vitiligo	2018
Omega-3 fatty acids supplementation with lithium and aripiprazole for improving the balance of circulating hormones and brain neurotransmitters in manic mice model. Naunyn-Schmiedeberg's archives of pharmacology, 2018, Volume: 391, Issue:3 Topics: Animals; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brain; Disease Models, Animal; Drug Therapy, Combination; Fatty Acids, Omega-3; Glycogen Synthase Kinase 3 beta; Hormones; Lithium Compounds; Male; Mice; Neurotransmitter Agents; Proto-Oncogene Proteins c-akt; RNA, Messenger	2018
Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie, 2018, Volume: 46, Issue:2 Topics: Aripiprazole; Bipolar Disorder; Drug Monitoring; Drug Packaging; Humans; Medication Adherence; Schizophrenia; Signal Processing, Computer-Assisted	2018
The advantages of introducing aripiprazole once-monthly 300 mg in the bipolar disorder-II maintenance treatment regime for 2 patients. Asian journal of psychiatry, 2018, Volume: 34 Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Administration Schedule; Female; Humans; Middle Aged; Treatment Outcome	2018
Inhibition of the dopamine transporter as an animal model of bipolar disorder mania: Locomotor response, neuroimmunological profile and pharmacological modulation. Journal of psychiatric research, 2018, Volume: 102 Topics: Animals; Antidepressive Agents; Aripiprazole; Bipolar Disorder; Brain; Cytokines; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Lithium; Locomotion; Male; Mice; Nerve Growth Factors; Piperazines; Time Factors; Valproic Acid	2018
Effectiveness Evaluation of Additional Risk Minimization Measures for Adolescent Use of Aripiprazole in the European Union: Results from a Post-Authorization Safety Study. Drug safety, 2018, Volume: 41, Issue:8 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cross-Sectional Studies; European Union; Female; Health Personnel; Humans; Male; Product Surveillance, Postmarketing; Risk Assessment	2018
Budget impact analysis of long-acting injectable aripiprazole once-monthly 400 mg in bipolar I disorder in the USA. Journal of comparative effectiveness research, 2018, Volume: 7, Issue:7 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Budgets; Cost-Benefit Analysis; Delayed-Action Preparations; Dibenzocycloheptenes; Drug Administration Schedule; Drug Costs; Health Care Costs; Heterocyclic Compounds, 4 or More Rings; Hospitalization; Humans; Injections, Intramuscular; Injections, Subcutaneous; Medication Adherence; Paliperidone Palmitate; Piperazines; Schizophrenia	2018
Aripiprazole and pregnancy: A retrospective, multicentre study. Journal of affective disorders, 2018, 10-01, Volume: 238 Topics: Adult; Antipsychotic Agents; Aripiprazole; Australia; Bipolar Disorder; Birth Weight; Female; Humans; Hypertension; Infant, Newborn; Maternal Exposure; Mental Disorders; Pregnancy; Pregnancy Complications; Retrospective Studies; Schizophrenia	2018
Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data. Advances in therapy, 2018, Volume: 35, Issue:10 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cohort Studies; Delayed-Action Preparations; Drug Administration Routes; Female; Humans; Insurance Claim Review; Male; Medication Adherence; Middle Aged; Retrospective Studies; Schizophrenia; Schizophrenic Psychology; United States	2018
Electroencephalogram Modifications Associated With Atypical Strict Antipsychotic Monotherapies. Journal of clinical psychopharmacology, 2018, Volume: 38, Issue:6 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cerebral Cortex; Clozapine; Depressive Disorder, Major; Electroencephalography; Female; Humans; Male; Mental Disorders; Middle Aged; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Young Adult	2018
Phenoconversion of CYP2D6 by inhibitors modifies aripiprazole exposure. European archives of psychiatry and clinical neuroscience, 2020, Volume: 270, Issue:1 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Female; Humans; Male; Middle Aged; Schizophrenia; Young Adult	2020
Impact of the CYP2D6 phenotype on hyperprolactinemia development as an adverse event of treatment with atypical antipsychotic agents in pediatric patients. Irish journal of medical science, 2019, Volume: 188, Issue:4 Topics: Adolescent; Alleles; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Cytochrome P-450 CYP2D6; Female; Humans; Hyperprolactinemia; Male; Phenotype; Prospective Studies; Psychotic Disorders; Risperidone; Schizophrenia; Young Adult	2019
Concurrent, successful management of bipolar I disorder with comorbid alcohol dependence via aripiprazole long-acting injection: A case report. Neuropsychopharmacology reports, 2019, Volume: 39, Issue:3 Topics: Alcoholism; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Injections, Intramuscular; Middle Aged	2019
Aripiprazole-associated acute dystonia, akathisia, and parkinsonism in a patient with bipolar I disorder. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:2 Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dystonia; Female; Humans; Parkinsonian Disorders; Piperazines; Quinolones	2013
Treatment of youth with bipolar disorder: long-term versus maintenance. Bipolar disorders, 2013, Volume: 15, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Male; Piperazines; Quinolones	2013
Safety first. Bipolar disorders, 2013, Volume: 15, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Male; Piperazines; Quinolones	2013
Effectiveness of a clozapine-aripiprazole combination in Tourette syndrome and bipolar spectrum disorder. The Journal of neuropsychiatry and clinical neurosciences, 2013,Winter, Volume: 25, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clozapine; Drug Therapy, Combination; Humans; Male; Piperazines; Quinolones; Tourette Syndrome	2013
Reversal of aripiprazole-induced tardive akathisia by addition of pregabalin. The Journal of neuropsychiatry and clinical neurosciences, 2013,Spring, Volume: 25, Issue:2 Topics: Adult; Akathisia, Drug-Induced; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; gamma-Aminobutyric Acid; Humans; Piperazines; Pregabalin; Quinolones	2013
An evaluation of inpatient treatment continuation and hospital readmission rates in patients with bipolar disorder treated with aripiprazole or quetiapine. Journal of psychiatric practice, 2013, Volume: 19, Issue:4 Topics: Adolescent; Adult; Age Factors; Aged; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Cohort Studies; Dibenzothiazepines; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospitalization; Hospitals, Psychiatric; Humans; Inpatients; Male; Middle Aged; Odds Ratio; Patient Readmission; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Valproic Acid; Young Adult	2013
Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011. Journal of affective disorders, 2014, Volume: 155 Topics: Academic Medical Centers; Adult; Ambulatory Care Facilities; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; California; Dibenzothiazepines; Drug Therapy; Female; Humans; Lamotrigine; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Referral and Consultation; Risperidone; Triazines	2014
Aripiprazole: a new risk factor for pathological gambling? A report of 8 case reports. Addictive behaviors, 2014, Volume: 39, Issue:3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dopamine Agonists; Female; Gambling; Humans; Male; Middle Aged; Piperazines; Quinolones; Risk Factors; Schizophrenia; Young Adult	2014
Reversible dopamine transporter reduction in drug-induced Parkinsonism. Movement disorders : official journal of the Movement Disorder Society, 2014, Volume: 29, Issue:4 Topics: Aged; Aripiprazole; Bipolar Disorder; Brain; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Lithium Carbonate; Parkinson Disease, Secondary; Piperazines; Quinolones; Radionuclide Imaging	2014
Effect of valproate on the plasma concentrations of aripiprazole in bipolar patients. International journal of psychiatry in clinical practice, 2014, Volume: 18, Issue:4 Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Quinolones; Retrospective Studies; Valproic Acid; Young Adult	2014
Combination of omega-3 Fatty acids, lithium, and aripiprazole reduces oxidative stress in brain of mice with mania. Biological trace element research, 2014, Volume: 160, Issue:3 Topics: Animals; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brain; Brain Chemistry; Disease Models, Animal; Fatty Acids, Omega-3; Glutathione; Lithium Compounds; Male; Mice; Oxidative Stress; Oxidoreductases; Piperazines; Quinolones	2014
Aripiprazole for the treatment of a manic patient with clozapine-related colonic obstruction receiving total colectomy. The Journal of neuropsychiatry and clinical neurosciences, 2014,Summer, Volume: 26, Issue:3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clozapine; Colectomy; Humans; Intestinal Obstruction; Male; Piperazines; Quinolones	2014
Suppression of antipsychotic-induced tardive dyskinesia with aripiprazole in an elderly patient with bipolar I disorder. Acta neuropsychiatrica, 2014, Volume: 26, Issue:1 Topics: Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dyskinesia, Drug-Induced; Humans; Male; Piperazines; Quinolones; Treatment Outcome	2014
Aripiprazole adjunct treatment in bipolar I or II disorder, depressed state: a 2-year clinical study. The Journal of nervous and mental disease, 2015, Volume: 203, Issue:1 Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Synergism; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Piperazines; Quinolones; Time Factors; Treatment Outcome; Young Adult	2015
Protein kinase C inhibition rescues manic-like behaviors and hippocampal cell proliferation deficits in the sleep deprivation model of mania. The international journal of neuropsychopharmacology, 2014, Oct-31, Volume: 18, Issue:2 Topics: Animals; Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzophenanthridines; Bipolar Disorder; Cell Proliferation; Disease Models, Animal; Fluoxetine; Hippocampus; Lithium Chloride; Male; Piperazines; Prefrontal Cortex; Protein Kinase C; Protein Kinase Inhibitors; Quinolones; Rats, Sprague-Dawley; Sleep Deprivation; Tamoxifen	2014
Here/In this issue and there/abstract thinking: trials in child psychiatry: and now … be more pragmatic, please! Journal of the American Academy of Child and Adolescent Psychiatry, 2015, Volume: 54, Issue:2 Topics: Adolescent; Aripiprazole; Bipolar Disorder; Child; Child Psychiatry; Child Rearing; Cognitive Behavioral Therapy; Humans; Paliperidone Palmitate; Periodicals as Topic; Pragmatic Clinical Trials as Topic; Schizophrenia	2015
Switching antipsychotic medication to aripiprazole: position paper by a panel of Italian psychiatrists. Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clozapine; Drug Substitution; Humans; Italy; Piperazines; Quinolones; Schizophrenia	2015
[Case of graves' disease with remarkable psychiatric symptoms]. Journal of UOEH, 2015, Mar-01, Volume: 37, Issue:1 Topics: Adult; Affective Disorders, Psychotic; Antipsychotic Agents; Antithyroid Agents; Aripiprazole; Bipolar Disorder; Delusions; Female; Graves Disease; Hallucinations; Humans; Lithium Compounds; Methimazole; Piperazines; Propranolol; Quinolones; Treatment Outcome	2015
Hiccups Associated with Aripiprazole in an Adolescent with Bipolar Disorder. Journal of child and adolescent psychopharmacology, 2016, Volume: 26, Issue:7 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Hiccup; Humans; Quinolones; Treatment Outcome	2016
The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: the 15-min challenge to sort these agents out. International journal of clinical practice, 2015, Volume: 69, Issue:11 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Humans; Piperazines; Quinolones; Schizophrenia; Thiophenes	2015
Remission of irreversible aripiprazole-induced tardive dystonia with clozapine: a case report. BMC psychiatry, 2015, Oct-19, Volume: 15 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clozapine; Dyskinesia, Drug-Induced; Humans; Male; Movement Disorders; Neurologic Examination; Psychotic Disorders; Treatment Outcome; Young Adult	2015
Effects of aripiprazole on the QTc: a case report. The Journal of clinical psychiatry, 2015, Volume: 76, Issue:12 Topics: Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Long QT Syndrome	2015
Changes in biomarkers of bone turnover in an aripiprazole add-on or switching study. Schizophrenia research, 2016, Volume: 170, Issue:2-3 Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Biomarkers; Bipolar Disorder; Bone Remodeling; Estrogens; Female; Follow-Up Studies; Humans; Male; Middle Aged; PAX5 Transcription Factor; Prolactin; Prospective Studies; Psychotic Disorders; Schizophrenia; Sensitivity and Specificity; Testosterone; Young Adult	2016
Aripiprazole for the Treatment of Antipsychotic-Induced Hyperprolactinemia in an Adolescent Boy. Journal of child and adolescent psychopharmacology, 2016, Volume: 26, Issue:5 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Hyperprolactinemia; Male; Prolactin; Quinolones; Schizophrenia	2016
Treat the disease not the symptoms: Successful management of obsessive compulsive disorder in bipolar disorder with aripiprazole augmentation. The Australian and New Zealand journal of psychiatry, 2016, Volume: 50, Issue:8 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Male; Obsessive-Compulsive Disorder	2016
Effectiveness of add-on l-methylfolate therapy in a complex psychiatric illness with MTHFR C677 T genetic polymorphism. Asian journal of psychiatry, 2016, Volume: 22 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Fluoxetine; Humans; Lithium Compounds; Male; Methylenetetrahydrofolate Reductase (NADPH2); Obsessive-Compulsive Disorder; Polymorphism, Genetic; Tetrahydrofolates; Vitamin B Complex	2016
Aripiprazole-related hyponatremia and consequent valproic acid-related hyperammonemia in one patient. The Australian and New Zealand journal of psychiatry, 2017, Volume: 51, Issue:3 Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Hyperammonemia; Hyponatremia; Valproic Acid	2017
Aripiprazole-Induced Hyperlipidemia: An Update. The primary care companion for CNS disorders, 2016, Aug-25, Volume: 18, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cholesterol; Humans; Hyperlipidemias; Male; Obsessive-Compulsive Disorder; Triglycerides	2016
Obsessive-Compulsive Symptoms Associated With Aripiprazole Treatment in Bipolar Disorder: A Case Report. Journal of clinical psychopharmacology, 2017, Volume: 37, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Obsessive-Compulsive Disorder	2017
Aripiprazole induced Impulse Control Disorders: Where do we stand? Asian journal of psychiatry, 2016, Volume: 23 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Male; Middle Aged; Psychotic Disorders; Schizophrenia; Young Adult	2016
The Utility of Low-Dose Aripiprazole for the Treatment of Bipolar II and Bipolar NOS Depression. Journal of clinical psychopharmacology, 2017, Volume: 37, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Young Adult	2017
Space-Time Cluster Analysis to Detect Innovative Clinical Practices: A Case Study of Aripiprazole in the Department of Veterans Affairs. Health services research, 2018, Volume: 53, Issue:1 Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Male; Middle Aged; Nurses; Physicians, Primary Care; Practice Patterns, Physicians'; Psychiatry; Residence Characteristics; Retrospective Studies; Space-Time Clustering; United States; United States Department of Veterans Affairs; Veterans	2018
Aripiprazole-Induced Hypersexuality. The primary care companion for CNS disorders, 2016, Dec-29, Volume: 18, Issue:6 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Male; Middle Aged; Sexual Dysfunctions, Psychological	2016
Improvement of a patient's circadian rhythm sleep disorders by aripiprazole was associated with stabilization of his bipolar illness. Journal of sleep research, 2017, Volume: 26, Issue:2 Topics: Adult; Aripiprazole; Bipolar Disorder; Circadian Rhythm; Disorders of Excessive Somnolence; Humans; Male; Middle Aged; Sleep; Sleep Disorders, Circadian Rhythm; Suprachiasmatic Nucleus	2017
Long-Acting Aripiprazole in Comorbid Bipolar Disorder and Borderline Personality Disorder and Substance Abuse. Journal of clinical psychopharmacology, 2017, Volume: 37, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Borderline Personality Disorder; Comorbidity; Humans; Male; Substance-Related Disorders	2017
Atypical permanent neurological sequelae after an acute intoxication with lithium and aripiprazole. Journal of affective disorders, 2017, Volume: 214 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Lithium Compounds; Male; Pseudobulbar Palsy; Psychomotor Disorders; Suicide, Attempted	2017
Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression. CNS spectrums, 2008, Volume: 13, Issue:6 Topics: Antipsychotic Agents; Aripiprazole; Benzazepines; Bipolar Disorder; Depressive Disorder; Female; Genetic Predisposition to Disease; Humans; Middle Aged; Piperazines; Psychoses, Substance-Induced; Psychotherapy; Quinolones; Quinoxalines; Smoking Cessation; Stress, Psychological; Varenicline	2008
Tolerability and pharmacokinetics of aripiprazole in children and adolescents with psychiatric disorders: an open-label, dose-escalation study. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:4 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Piperazines; Quinolones; Schizophrenia	2008
Aripiprazole joins the family of second-generation mood stabilizers. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Piperazines; Quinolones; Treatment Outcome	2008
Practical guidance for prescribing with aripiprazole in bipolar disorder. Current medical research and opinion, 2008, Volume: 24, Issue:9 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Male; Piperazines; Quinolones	2008
Aripiprazole-induced orthostatic hypotension and cardiac arrhythmia. Psychiatry and clinical neurosciences, 2008, Volume: 62, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dose-Response Relationship, Drug; Female; Humans; Hypotension, Orthostatic; Middle Aged; Piperazines; Quinolones; Schizophrenia; Tachycardia, Supraventricular	2008
Bipolar drug development: are we getting closer to the real world? The American journal of psychiatry, 2008, Volume: 165, Issue:10 Topics: Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Therapy, Combination; Humans; Lithium Compounds; Patient Dropouts; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome; Valproic Acid	2008
A UK consensus on the administration of aripiprazole for the treatment of mania. Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clinical Trials as Topic; Humans; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quinolones; United Kingdom	2009
Predictors of aripiprazole treatment continuation in hospitalized patients. The Journal of clinical psychiatry, 2008, Volume: 69, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Child, Preschool; Cohort Studies; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Patient Discharge; Piperazines; Psychotic Disorders; Quinolones; Retrospective Studies; Treatment Outcome	2008
Aripiprazole-induced sialorrhea. Progress in neuro-psychopharmacology & biological psychiatry, 2009, Mar-17, Volume: 33, Issue:2 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder; Humans; Male; Piperazines; Quinolones; Sialorrhea; Valproic Acid	2009
Refractory restless legs syndrome likely caused by olanzapine. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2009, Feb-15, Volume: 5, Issue:1 Topics: Anticonvulsants; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Middle Aged; Olanzapine; Piperazines; Quinolones; Restless Legs Syndrome; Valproic Acid	2009
Multiple sclerosis presenting with erotomanic delusions in the context of "Don't ask, don't tell". Military medicine, 2009, Volume: 174, Issue:3 Topics: Adjuvants, Immunologic; Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Erotica; Female; Humans; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Military Personnel; Military Psychiatry; Multiple Sclerosis; Organizational Policy; Piperazines; Quinolones; Recognition, Psychology; Schizophrenia, Paranoid; Sex Offenses; Sexual Harassment; Stress, Psychological; Syndrome	2009
Maintenance treatment received by patients with bipolar I and II disorders--a naturalistic prospective study. Journal of affective disorders, 2010, Volume: 121, Issue:1-2 Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lamotrigine; Lithium Carbonate; Long-Term Care; Male; Middle Aged; Olanzapine; Oxcarbazepine; Piperazines; Prospective Studies; Quinolones; Risperidone; Triazines; Valproic Acid	2010
Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone. Journal of medical economics, 2009, Volume: 12, Issue:2 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Costs and Cost Analysis; Dibenzothiazepines; Drug Therapy, Combination; Female; Health Care Costs; Humans; Male; Middle Aged; Mood Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Thiazoles; Treatment Outcome; Young Adult	2009
Aripiprazole: new indication. Treatment and prevention of manic episodes: just another neuroleptic. Prescrire international, 2009, Volume: 18, Issue:101 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clinical Trials as Topic; Drug Approval; Europe; Humans; Piperazines; Quinolones	2009
Waxing-and-waning catatonia after intermittent exposure to aripiprazole in a case of autism and bipolar disorder. Journal of clinical psychopharmacology, 2009, Volume: 29, Issue:5 Topics: Adult; Aripiprazole; Autistic Disorder; Bipolar Disorder; Catatonia; Humans; Male; Piperazines; Quinolones	2009
Life events, medical comorbidity, and somatic symptoms in pediatric mood disorders. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:10 Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Comorbidity; Female; Humans; Hungary; Life Change Events; Male; Mood Disorders; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Somatoform Disorders; United States	2009
Antipsychotic prescribing practices following withdrawal of concomitant carbamazepine. Journal of psychiatric practice, 2009, Volume: 15, Issue:6 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Carbamazepine; Cytochrome P-450 Enzyme System; Dibenzothiazepines; Drug Interactions; Drug Therapy, Combination; Enzyme Induction; Female; Humans; Male; Medical Audit; Middle Aged; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risk Factors; Risperidone	2009
Pediatric bipolar disorder. Journal of psychosocial nursing and mental health services, 2009, Volume: 47, Issue:12 Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Child Psychiatry; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Humans; Lithium Carbonate; Nursing Assessment; Parents; Patient Education as Topic; Piperazines; Psychiatric Nursing; Psychotherapy; Quinolones; Risperidone; Social Support	2009
Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania. The international journal of neuropsychopharmacology, 2010, Volume: 13, Issue:4 Topics: Animals; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Central Nervous System Stimulants; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Locomotion; Male; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Self Stimulation	2010
Aripiprazole induced acute dystonia after discontinuation of a stimulant medication. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:1 Topics: Acute Disease; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Drug Administration Schedule; Dystonia; Humans; Male; Methylphenidate; Piperazines; Quinolones; Substance Withdrawal Syndrome	2010
Treatment with aripiprazole for hyperprolactinemia induced by pituitary microadenoma in a bipolar I disorder patient. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:1 Topics: Adenoma; Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dopamine Antagonists; Female; Humans; Hyperprolactinemia; Piperazines; Pituitary Neoplasms; Quinolones	2010
Symptomatic bradycardia with oral aripiprazole and oral ziprasidone. The Annals of pharmacotherapy, 2010, Volume: 44, Issue:4 Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Bradycardia; Delusions; Electrocardiography; Female; Humans; Lithium Carbonate; Piperazines; Psychotic Disorders; Quinolones; Thiazoles	2010
Potential control of antipsychotic-induced hyperprolactinemia and obesity in children and adolescents by aripiprazole. Progress in neuro-psychopharmacology & biological psychiatry, 2010, Aug-16, Volume: 34, Issue:6 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Humans; Hyperprolactinemia; Obesity; Piperazines; Quinolones; Schizophrenia	2010
[Long-term (prophylactic) therapy of bipolar patients with aripiprazole]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2010, Volume: 12, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Middle Aged; Piperazines; Quinolones; Treatment Outcome	2010
Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder. PharmacoEconomics, 2010, Volume: 28, Issue:9 Topics: Absenteeism; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Cost-Benefit Analysis; Delayed-Action Preparations; Dibenzothiazepines; Drug Therapy, Combination; Fees, Pharmaceutical; Health Care Costs; Hospital Charges; Humans; Lamotrigine; Lithium Compounds; Markov Chains; Models, Economic; Olanzapine; Piperazines; Quality-Adjusted Life Years; Quetiapine Fumarate; Quinolones; Risk; Tablets; Triazines; United States; Valproic Acid	2010
Metabolic syndrome and its potential effect on treatment response to aripiprazole: a post hoc analysis of the stabilization phase of a long-term, double-blind study in patients with bipolar disorder (CN138-010). Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:5 Topics: Aripiprazole; Bipolar Disorder; Double-Blind Method; Humans; Metabolic Syndrome; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome	2010
Epidemiologic study of aripiprazole use and the incidence of suicide events. Pharmacoepidemiology and drug safety, 2010, Volume: 19, Issue:11 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Databases, Factual; Female; Humans; Incidence; Male; Middle Aged; Piperazines; Quinolones; Risk; Schizophrenia; Suicide; Suicide, Attempted; Young Adult	2010
Three cases of hypomania and one case of mania during aripiprazole treatment. Pharmacopsychiatry, 2011, Volume: 44, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Young Adult	2011
Aripiprazole-associated bruxism, akathisia, and parkinsonism in a bipolar patient. Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:1 Topics: Akathisia, Drug-Induced; Aripiprazole; Bipolar Disorder; Bruxism; Female; Humans; Parkinson Disease, Secondary; Piperazines; Quinolones; Young Adult	2011
Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services. The Journal of clinical psychiatry, 2011, Volume: 72, Issue:4 Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Clozapine; Crime; Delayed-Action Preparations; Dibenzothiazepines; Female; Florida; Humans; Isoxazoles; Male; Medicaid; Middle Aged; Olanzapine; Outpatients; Paliperidone Palmitate; Piperazines; Propensity Score; Pyrimidines; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Schizophrenia; Treatment Outcome; United States; Young Adult	2011
[Aripiprazole-induced parkinsonism in a 64-year-old female patient diagnosed with bipolar disorder]. Tijdschrift voor psychiatrie, 2011, Volume: 53, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Middle Aged; Parkinson Disease; Piperazines; Quinolones	2011
Metabolic effects and cost-effectiveness of aripiprazole versus olanzapine in schizophrenia and bipolar disorder. Acta psychiatrica Scandinavica, 2011, Volume: 124, Issue:3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Coronary Disease; Costs and Cost Analysis; Female; Humans; Male; Metabolic Diseases; Metabolism; Middle Aged; Olanzapine; Piperazines; Quality-Adjusted Life Years; Quinolones; Risk Assessment; Schizophrenia; Sweden	2011
Safety of antipsychotics in the setting of QTc prolongation: the utility of the JT index. The American journal of psychiatry, 2011, Volume: 168, Issue:9 Topics: Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Bundle-Branch Block; Combined Modality Therapy; Cooperative Behavior; Electrocardiography; Electroconvulsive Therapy; Female; Haloperidol; Humans; Interdisciplinary Communication; Long QT Syndrome; Piperazines; Quinolones; Risk Factors; Torsades de Pointes	2011
Confounding by indication of a specific antipsychotic and the increase of body mass index among children and adolescents. European child & adolescent psychiatry, 2011, Volume: 20, Issue:11-12 Topics: Adolescent; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Benzodiazepines; Bipolar Disorder; Body Mass Index; Body Weight; Child; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Spain; Time Factors	2011
Manic induction with interferon alpha therapy. The Australian and New Zealand journal of psychiatry, 2011, Volume: 45, Issue:11 Topics: Adult; Antipsychotic Agents; Antiviral Agents; Aripiprazole; Bipolar Disorder; Hepatitis C; Humans; Interferon-alpha; Male; Piperazines; Quinolones; Schizophrenia	2011
Aripiprazole augmentation treatment in treatment resistant bipolar depression: two patient reports. Turk psikiyatri dergisi = Turkish journal of psychiatry, 2011,Winter, Volume: 22, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Treatment-Resistant; Drug Administration Schedule; Female; Humans; Piperazines; Psychiatric Status Rating Scales; Quinolones	2011
Neurocognitive effects of aripiprazole in adolescents and young adults with bipolar disorder. Nordic journal of psychiatry, 2012, Volume: 66, Issue:4 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brief Psychiatric Rating Scale; Cognition; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Piperazines; Prospective Studies; Quinolones; Severity of Illness Index; Taiwan; Young Adult	2012
Intermittent aripiprazole for schizophrenia. Schizophrenia research, 2012, Volume: 134, Issue:2-3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Retrospective Studies; Schizophrenia	2012
Efficacy of aripiprazole in comorbid addiction in bipolar disorder. CNS neuroscience & therapeutics, 2012, Volume: 18, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Male; Piperazines; Quinolones; Substance-Related Disorders; Treatment Outcome	2012
Impulse control loss rapidly reversed by aripiprazole in a patient with concomitant bipolar disease type I and posttraumatic frontal lobe lesions. BMJ case reports, 2011, Dec-01, Volume: 2011 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brain Injuries; Disruptive, Impulse Control, and Conduct Disorders; Humans; Male; Middle Aged; Piperazines; Quinolones	2011
Improvement in intractable tardive dystonia in bipolar disorder after aripiprazole treatment: a case report. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Resistance; Humans; Male; Movement Disorders; Piperazines; Quinolones	2012
A UK panel consensus on the initiation of aripiprazole for the treatment of bipolar mania. International journal of psychiatry in clinical practice, 2012, Volume: 16, Issue:4 Topics: Acute Disease; Anhedonia; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Administration Schedule; Drug Therapy, Combination; Humans; Long-Term Care; Metabolic Diseases; Patient Participation; Piperazines; Psychomotor Agitation; Quinolones; Randomized Controlled Trials as Topic; Recovery of Function; Sexual Dysfunction, Physiological; Treatment Outcome	2012
Graves' hyperthyroidism-induced psychosis treated with aripiprazole--a case report. Journal of pharmacy practice, 2013, Volume: 26, Issue:1 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Graves Disease; Humans; Middle Aged; Piperazines; Psychotic Disorders; Quinolones	2013
Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study. BMC psychiatry, 2012, Aug-02, Volume: 12 Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Databases, Factual; Dibenzothiazepines; Female; Humans; Male; Medication Adherence; Patient Discharge; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Schizophrenia; Thiazoles	2012
Heterogeneity in aripiprazole diffusion for bipolar disorder treatment in the Veterans Health Administration. Psychiatric services (Washington, D.C.), 2012, Volume: 63, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cross-Sectional Studies; Diffusion of Innovation; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Registries; United States; United States Department of Veterans Affairs; United States Food and Drug Administration	2012
Hypomania associated with adjunctive aripiprazole in an elder female with recurrent major depressive disorder: dose-related phenomenon? Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:6 Topics: Aripiprazole; Bipolar Disorder; Clonazepam; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Piperazines; Quinolones; Recurrence	2012
Rhabdomyolysis in a patient on aripiprazole with traumatic hip prosthesis luxation. The Journal of neuropsychiatry and clinical neurosciences, 2012,Fall, Volume: 24, Issue:4 Topics: Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Arthroplasty, Replacement, Hip; Bipolar Disorder; Female; Hip Prosthesis; Humans; Piperazines; Prosthesis Failure; Quinolones; Rhabdomyolysis	2012
Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia. Current medical research and opinion, 2013, Volume: 29, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Haloperidol; Humans; Hypnotics and Sedatives; Olanzapine; Piperazines; Psychomotor Agitation; Quinolones; Schizophrenia; Tranquilizing Agents	2013
Neural correlates of treatment response in depressed bipolar adolescents during emotion processing. Brain imaging and behavior, 2013, Volume: 7, Issue:2 Topics: Adolescent; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brain; Citalopram; Depressive Disorder; Dibenzothiazepines; Drug Therapy, Combination; Emotions; Facial Expression; Female; Humans; Lamotrigine; Magnetic Resonance Imaging; Male; Piperazines; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Sertraline; Triazines; Valproic Acid	2013
Possible increased efficacy of low-dose clozapine when combined with aripiprazole. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:9 Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clozapine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia, Paranoid; Treatment Outcome	2004
The risk of harm in mania and the very early time course of improvement: important but neglected variables in treatment research. Bipolar disorders, 2004, Volume: 6, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Humans; Olanzapine; Piperazines; Quality of Life; Quinolones; Risk Factors; Self-Injurious Behavior; Thiazoles	2004
Aripiprazole for acute bipolar mania. The American journal of psychiatry, 2004, Volume: 161, Issue:10 Topics: Acute Disease; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Multicenter Studies as Topic; Piperazines; Placebos; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Treatment Outcome	2004
Aripiprazole in the treatment of bipolar disorder in children and adolescents. Journal of child and adolescent psychopharmacology, 2004,Winter, Volume: 14, Issue:4 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Male; Piperazines; Quinolones	2004
The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review. Journal of child and adolescent psychopharmacology, 2004,Winter, Volume: 14, Issue:4 Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Child, Preschool; Female; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Retrospective Studies; Treatment Outcome	2004
Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review. CNS spectrums, 2005, Volume: 10, Issue:2 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Quinolones; Treatment Outcome	2005
Aripiprazole and depression in schizoaffective disorder. The American journal of psychiatry, 2005, Volume: 162, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Comorbidity; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Quinolones; Treatment Outcome	2005
Improvement in tardive dyskinesia with aripiprazole use. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2005, Volume: 50, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Long-Term Care; Middle Aged; Piperazines; Quinolones; Risperidone; Valproic Acid	2005
TrkB partial agonists: potential treatment strategy for epilepsy, mania, and autism. Medical hypotheses, 2006, Volume: 66, Issue:1 Topics: Aripiprazole; Autistic Disorder; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Epilepsy; Humans; Piperazines; Quinolones; Receptor, trkB; Signal Transduction	2006
Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients. Journal of psychiatric practice, 2005, Volume: 11, Issue:4 Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Mathematical Computing; Middle Aged; Obesity; Piperazines; Product Surveillance, Postmarketing; Psychotic Disorders; Quinolones; Receptors, Dopamine D2; Schizophrenia; Treatment Outcome	2005
Aripiprazole in children and adolescents: clinical experience. Journal of child neurology, 2005, Volume: 20, Issue:7 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Bipolar Disorder; Child; Child Behavior Disorders; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Male; Piperazines; Prospective Studies; Quinolones; Retrospective Studies; Treatment Outcome; Treatment Refusal	2005
Treatment of withdrawal dyskinesia. Journal of the American Academy of Child and Adolescent Psychiatry, 2005, Volume: 44, Issue:11 Topics: Adolescent; Amino Acids, Branched-Chain; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Male; Neurologic Examination; Piperazines; Quinolones; Substance Withdrawal Syndrome; Treatment Outcome	2005
Is there a real difference between the first onset of efficacy for atypical antipsychotic monotherapies in acute bipolar mania? The Journal of clinical psychiatry, 2005, Volume: 66, Issue:10 Topics: Acute Disease; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clinical Trials as Topic; Humans; Outcome Assessment, Health Care; Piperazines; Psychiatric Status Rating Scales; Quinolones; Research Design; Risperidone; Sensitivity and Specificity; Time Factors; Treatment Outcome	2005
Treatment-emergent psychosis with aripiprazole. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:10 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Middle Aged; Piperazines; Psychoses, Substance-Induced; Psychotic Disorders; Quinolones	2005
Priapism associated with oxcarbazepine, aripiprazole, and lithium. Journal of the American Academy of Child and Adolescent Psychiatry, 2005, Volume: 44, Issue:12 Topics: Adolescent; Affective Symptoms; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Carbamazepine; Child; Child Development Disorders, Pervasive; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Lithium Carbonate; Male; Oxcarbazepine; Penile Erection; Piperazines; Priapism; Quinolones	2005
Aripiprazole-induced movement disorder. The American journal of psychiatry, 2006, Volume: 163, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Piperazines; Quinolones; Syndrome	2006
Improvement or worsening of psychotic symptoms after treatment with low doses of aripiprazole. The international journal of neuropsychopharmacology, 2007, Volume: 10, Issue:1 Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Piperazines; Psychoses, Substance-Induced; Psychotic Disorders; Quinolones; Schizophrenia; Serotonin Agents; Treatment Outcome	2007
Aripiprazole-induced acute dystonia. The American journal of psychiatry, 2006, Volume: 163, Issue:6 Topics: Acute Disease; Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dystonia; Humans; Male; Muscarinic Antagonists; Piperazines; Quinolones; Torticollis; Trihexyphenidyl	2006
Questionable advertising of psychotropic medications and disease mongering. PLoS medicine, 2006, Volume: 3, Issue:7 Topics: Advertising; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Industry; Humans; Piperazines; Psychotropic Drugs; Quinolones	2006
Neuroleptic malignant syndrome with aripiprazole and lithium: a case report. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:4 Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Lithium; Male; Neuroleptic Malignant Syndrome; Piperazines; Quinolones	2006
Advanced pediatric psychopharmacology. Journal of child and adolescent psychopharmacology, 2006, Volume: 16, Issue:4 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cannabinoids; Combined Modality Therapy; Comorbidity; Drug Therapy, Combination; Humans; Male; Marijuana Abuse; Mental Status Schedule; Neuroleptic Malignant Syndrome; Patient Readmission; Piperazines; Prognosis; Psychoses, Substance-Induced; Quinolones; Recurrence; Social Environment; Thiazoles; Treatment Refusal	2006
Does antipsychotic polypharmacy increase the risk for metabolic syndrome? Schizophrenia research, 2007, Volume: 89, Issue:1-3 Topics: Adult; Age Factors; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Mass Index; Cholesterol, HDL; Clozapine; Cross-Sectional Studies; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Piperazines; Quetiapine Fumarate; Quinolones; Risk Factors; Schizophrenia; Thiazoles; Triglycerides	2007
Adjunctive aripiprazole in bipolar I depression. The Annals of pharmacotherapy, 2007, Volume: 41, Issue:1 Topics: Adult; Aged, 80 and over; Aripiprazole; Bipolar Disorder; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Retrospective Studies	2007
Manic episode during treatment with aripiprazole. The American journal of psychiatry, 2007, Volume: 164, Issue:1 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Middle Aged; Piperazines; Psychotic Disorders; Quinolones	2007
Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial. Journal of affective disorders, 2007, Volume: 101, Issue:1-3 Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Patient Dropouts; Pilot Projects; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones	2007
Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia. Progress in neuro-psychopharmacology & biological psychiatry, 2007, Mar-30, Volume: 31, Issue:2 Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Synergism; Female; Humans; Male; Middle Aged; Piperazines; Quinolones	2007
Acute dystonia associated with aripiprazole in a child. Journal of the American Academy of Child and Adolescent Psychiatry, 2007, Volume: 46, Issue:3 Topics: Acute Disease; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Dystonia; Humans; Male; Piperazines; Quinolones; Receptors, Dopamine D2	2007
A case of aripiprazole-induced mania. Pharmacopsychiatry, 2007, Volume: 40, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dibenzothiazepines; Humans; Male; Mood Disorders; Piperazines; Quetiapine Fumarate; Quinolones; Schizophrenia, Paranoid	2007
Aripiprazole-induced hyponatremia: a case report. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:4 Topics: Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Hyponatremia; Male; Piperazines; Quinolones	2007
Aripiprazole augmentation for treatment-resistant bipolar depression: sustained remission after 36 months. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Prospective Studies; Quinolones; Treatment Outcome	2007
Intramuscular aripiprazole in the control of agitation. Journal of psychiatric practice, 2007, Volume: 13, Issue:3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Arousal; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Multicenter Studies as Topic; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2007
Aripiprazole in a patient susceptible to urinary side effects of antipsychotics. The Israel journal of psychiatry and related sciences, 2007, Volume: 44, Issue:1 Topics: Adult; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Humans; Male; Piperazines; Quinolones; Urinary Retention	2007
Paradoxical motor syndrome following a switch from atypical neuroleptics to aripiprazole. The American journal of psychiatry, 2007, Volume: 164, Issue:9 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dopamine D2 Receptor Antagonists; Female; Humans; Middle Aged; Parkinsonian Disorders; Piperazines; Quinolones; Receptors, Dopamine D2	2007
Resolution of haloperidol-induced hyperprolactinemia with aripiprazole. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:5 Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clonazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Gynecomastia; Haloperidol; Humans; Hyperprolactinemia; Male; Piperazines; Prolactin; Quinolones; Valproic Acid	2007
Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:9 Topics: Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Data Interpretation, Statistical; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Psychomotor Agitation; Quinolones; Severity of Illness Index; Surveys and Questionnaires	2007
Practical strategies for assessing and stabilizing bipolar patients in urgent situations. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:10 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Emergency Services, Psychiatric; Humans; Impulsive Behavior; Injections, Intramuscular; Olanzapine; Piperazines; Practice Guidelines as Topic; Quinolones; Risperidone; Suicide, Attempted; Thiazoles; Time Factors	2007
Photo-onycholysis caused by olanzapine and aripiprazole. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Erythema; Female; Humans; Middle Aged; Olanzapine; Onycholysis; Photosensitivity Disorders; Piperazines; Quinolones	2008
Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trials. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:2 Topics: Affective Symptoms; Aggression; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Conduct Disorder; Double-Blind Method; Humans; Irritable Mood; Mood Disorders; Multicenter Studies as Topic; Piperazines; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome	2008
Delayed presentation of an aripiprazole overdose. Clinical toxicology (Philadelphia, Pa.), 2008, Volume: 46, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Disorders of Excessive Somnolence; Drug Overdose; Female; Half-Life; Humans; Piperazines; Quinolones; Suicide, Attempted; Time Factors	2008